Alzheimer’s disease (Late onset)

AD_LO

Alzheimer's disease: A progressive, neurodegenerative disease characterized by loss of function and death of nerve cells in several areas of the brain leading to loss of cognitive function such as memory and language.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F00.1, F00.10, F00.10G30.1, G30.1, G30.1+F00.10 Cause of death:* ICD-10 — F00.1, F00.10, F00.10*G30.1, G30.1, G30.1+F00.10 2 out of 7 registries used, show all original rules.	14561
4. Check minimum number of events None	14561
5. Include endpoints None	14561
6. Filter based on genotype QC (FinnGen only)	12743

Control definitions (FinnGen only)

Control exclude: G6_ALZHEIMER

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	AD_LO
CONTROL_EXCLUDE	G6_ALZHEIMER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F001\|G301
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F001\|G301
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Alzheimer’s disease (Late onset) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Alzheimer’s disease (Late onset), excluding more controls

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12743	6326	6417
Unadjusted period prevalence (%)	2.60	2.25	2.94
Median age at first event (years)	81.11	81.15	81.07

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12436: Matched controls
102320

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F00.10

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

118.9

307.7

1445

113

N05AH04

ATC

quetiapine; oral

4.0

307.7

2867

7107

SPAT1053

SPAT

Memory test

3.2

307.7

4475

15309

P20

ICPC

Memory disturbance

7.4

307.7

6566

13500

G30.0

ICD-10 Finland

Alzheimer disease with early onset

258.8

307.7

599

F00.9

ICD-10 Finland

Dementia in Alzheimer disease, unspecified

39.1

307.7

414

F0019, G301,

ICD-10 Finland

6932.7

307.7

798

N05AX08

ATC

risperidone; systemic

10.0

307.7

3936

4542

G30.1

ICD-10 Finland

Alzheimer disease with late onset

408.4

307.7

10475

1321

F00.20*G30.8

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

9.2

307.7

833

795

WYA20

NOMESCO Finland

Home visit

6.2

307.7

767

1076

N06DX01

ATC

memantine; oral

66.4

307.7

8326

3028

F00.10*G30.1

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms

76.2

307.7

4754

824

F03

ICD-10 Finland

Unspecified dementia

5.3

307.7

2245

4064

F00.14

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms of mixed type

107.4

307.7

218

N05BA04

ATC

oxazepam; oral

2.3

307.7

4052

17941

F05.1

ICD-10 Finland

Delirium superimposed on dementia

11.3

307.7

419

316

N06DA04

ATC

galantamine; oral

15.1

307.7

1650

1025

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

78.6

307.7

4383

704

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

166.4

307.7

3434

234

P70

ICPC

Dementia

16.7

307.7

1874

1077

N06DA03

ATC

rivastigmine; oral, transdermal

24.1

307.7

4020

1988

R41.3

ICD-10 Finland

Other amnesia

5.5

307.7

1135

1836

G30.8

ICD-10 Finland

Other Alzheimer disease

32.6

307.7

1234

345

A28

ICPC

Limited function/disability NOS

2.7

307.7

5016

20461

F06.7

ICD-10 Finland

Mild cognitive disorder

4.2

307.7

1102

2308

N06DA02

ATC

donepezil; oral

41.4

307.7

6342

2511

G30

ICD-10 Finland

Alzheimer disease

45.7

307.7

1002

196

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

130.3

307.7

487

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.5

307.7

4125

7257

F009, G309,

ICD-10 Finland

897.1

302.9

319

SPAT1245

SPAT

Provision of support and information to patient’s family members

3.2

287.6

1302

3587

F001, G301,

ICD-10 Finland

142.6

284.8

171

R53

ICD-10 Finland

Malaise and fatigue

2.1

284.1

4101

19559

F00.20

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without additional symptoms

16.3

283.4

272

140

F00.1

ICD-10 Finland

Dementia in Alzheimer disease with late onset

138.4

275.8

166

F00.19

ICD-10 Finland

Dementia in Alzheimer's disease with late onset without information about additional symptoms

110.4

259.5

159

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

254.5

2124

8047

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

248.7

5371

29153

I67.3

ICD-10 Finland

Progressive vascular leukoencephalopathy

5.1

246.6

566

939

F00.00

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

97.4

245.1

152

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.0

225.7

3150

14621

N06AX11

ATC

mirtazapine; oral

1.9

223.9

4369

22736

SPAT1216

SPAT

Assessment of functional ability

2.0

221.6

3195

14988

N05AH03

ATC

olanzapine; systemic

3.9

218.0

715

1582

N03AG01

ATC

valproic acid; systemic, rectal

3.5

214.6

825

2037

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.3

191.3

1663

6356

F0014, G301,

ICD-10 Finland

283.9

187.7

205

R41.0

ICD-10 Finland

Disorientation, unspecified

3.1

186.9

870

2418

N06AX26

ATC

vortioxetine; oral

3.3

185.5

776

2020

TAB00

NOMESCO Finland

Lumbar puncture

4.1

184.0

561

1174

SPAT1234

SPAT

Support of social functional capacity

2.6

181.1

1238

4230

N02AA05

ATC

oxycodone; systemic

1.8

177.0

3456

17718

F0009, G300,

ICD-10 Finland

+∞

170.3

176

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.7

170.2

1074

3522

F00.11

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly paranoidism

69.6

168.9

109

N06AB10

ATC

escitalopram; oral

2.2

164.9

1748

7223

F00

ICD-10 Finland

Dementia in Alzheimer disease

13.9

163.3

169

101

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

150.3

3853

21192

A04

ICPC

Weakness/tiredness general

1.9

148.2

2528

12320

N02BE01

ATC

paracetamol; systemic, rectal

2.0

147.6

10577

76200

Z75.5

ICD-10 Finland

Holiday relief care

5.1

147.4

339

562

N05AD01

ATC

haloperidol; systemic

3.0

146.3

705

1994

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

2.1

140.5

1599

6762

N05BA06

ATC

lorazepam; systemic, sublingual

2.5

135.9

937

3199

AA1AD

NOMESCO Finland

CT of head and brain

1.6

132.3

4624

27350

AXX01, ,

SPAT

2.5

126.4

874

2985

SPAT1254

SPAT

Administration of medicine

1.8

125.8

2521

12824

S72.0

ICD-10 Finland

Fracture of neck of femur

2.2

120.1

1085

4173

OAB76

NOMESCO Finland

General guidance on nutrition and food

12.3

117.2

130

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

112.4

2691

14331

AXX01

NOMESCO Finland

Memory assessment

6.2

111.4

206

276

NFB20

NOMESCO Finland

Primary partial prosthetic replacement of hip joint using cement, other or unspecified

2.5

111.2

747

2512

XA800

NOMESCO Finland

Neuropsychological investigation

3.6

108.0

387

907

L28

ICPC

Limited function/disability (L)

1.6

106.2

3355

19128

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

104.5

4635

28534

OAB48

NOMESCO Finland

Lifestyle advice and guidance

10.6

102.4

124

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

3.7

100.2

341

771

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

100.0

2372

12548

A06AD11

ATC

lactulose; oral

1.6

100.0

2863

15896

OAB41

NOMESCO Finland

Guidance and counselling related to ageing

7.0

99.4

164

194

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.3

97.2

853

3233

S01.0

ICD-10 Finland

Open wound of scalp

2.0

95.2

1264

5604

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

94.8

2541

13850

SPAT1246

SPAT

Screening of depression or other psychiatric problem

3.6

94.7

337

786

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

93.9

2250

27285

130

Kela drug reimbursment

Malignant tumour

0.3

92.1

314

7628

U04

ICPC

Incontinence urine

2.0

90.8

1122

4848

F0011, G301,

ICD-10 Finland

107.9

89.3

104

R1250

NOMESCO Finland

Evaluation of functional capability

3.2

85.8

362

943

R55

ICD-10 Finland

Syncope and collapse

1.7

83.7

1895

9851

A29

ICPC

General symptom/complaint other

1.7

82.2

1943

10212

N06AB06

ATC

sertraline; oral

2.1

81.9

905

3751

R41

ICD-10 Finland

Other symptoms and signs involving cognitive functions and awareness

4.5

80.6

209

384

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.6

79.8

1604

20481

S06.0

ICD-10 Finland

Concussion

1.8

79.7

1340

6394

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

77.5

893

3756

SPAT1360

SPAT

Extensive global examination

1.9

77.4

1047

4657

Z01.9

ICD-10 Finland

Special examination, unspecified

2.1

75.8

764

3054

Z29

ICPC

Social problem NOS

3.1

74.4

327

873

N06AB04

ATC

citalopram; systemic

1.6

73.3

2288

12837

F0029, G308,

ICD-10 Finland

628.2

71.6

F00.12

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset, other additional symptoms, mainly hallucinations

317.1

71.0

F21, ,

ICPC

3.9

71.0

227

491

SPAT1101

SPAT

Orthostatic test

2.0

70.7

875

3772

J01CA08

ATC

pivmecillinam; oral

1.4

69.6

4314

27759

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.5

67.6

885

12782

H02AB02

ATC

dexamethasone; systemic

0.4

65.6

360

7084

N30.0

ICD-10 Finland

Acute cystitis

1.5

65.0

2198

12517

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.6

65.0

1735

9355

N07AA05, ,

ATC

569.9

64.9

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

64.6

969

4450

F05.9

ICD-10 Finland

Delirium, unspecified

2.4

64.0

477

1679

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

2.3

63.5

524

1929

SPAT1252

SPAT

Overall medication plan or its review

1.8

59.3

1088

5306

W19

ICD-10 Finland

Unspecified fall

1.7

59.1

1354

7014

N27

ICPC

Fear of neurological disease other

2.8

58.2

317

956

SAD01

NOMESCO Finland

Assessment of need for oral health care, standard

1.7

56.9

1097

5422

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.8

55.9

866

4013

R42

ICD-10 Finland

Dizziness and giddiness

1.4

55.6

3313

20977

SPAT1139

SPAT

Nutrition survey

2.2

55.0

519

2019

SPAT1301

SPAT

No procedures

1.4

52.3

3929

25796

J01DB01

ATC

cefalexin; oral

1.4

51.3

8670

64229

F01.20

ICD-10 Finland

Subcortical vascular dementia without additional symptoms

3.0

50.7

232

635

R5110, ,

SPAT

1.6

50.5

1290

6854

A03FA01

ATC

metoclopramide; systemic, rectal

0.6

50.4

1290

15822

S70.0

ICD-10 Finland

Contusion of hip

1.9

49.5

641

2799

N05AD03

ATC

melperone; systemic

2.9

48.9

251

733

F00.24

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms of mixed type

22.6

48.9

EB1VA, ,

NOMESCO Finland

0.5

47.6

419

6925

F0012, G301,

ICD-10 Finland

78.5

47.5

SPAT1304

SPAT

Counselling and guidance related to ageing

1.5

47.3

1465

8133

J01EA01

ATC

trimethoprim; systemic

1.4

47.0

3298

21340

LAITO, ,

NOMESCO Finland

10.8

46.8

G40.9

ICD-10 Finland

Epilepsy, unspecified

2.2

45.7

419

1610

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

45.4

1263

6837

E86

ICD-10 Finland

Volume depletion

2.1

45.0

475

1929

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.6

44.4

1345

7424

F00.13

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, senile onset other additional symptoms, mainly depression

56.9

43.9

F00.01

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly paranoidism

198.2

43.4

ICB01, ,

SPAT

4.9

43.0

100

168

SPAT1153

SPAT

Removal of sutures

0.7

42.6

2325

24835

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.0

42.4

505

2142

F0013, G301,

ICD-10 Finland

+∞

41.5

B03BA03

ATC

hydroxocobalamin; parenteral

1.6

41.0

955

4948

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

41.0

1737

10263

AA1AD, ,

SPAT

3.4

39.9

153

376

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

39.6

794

3956

NFJ54

NOMESCO Finland

Internal fixation of fracture of upper femur with intramedullary nail

2.2

38.8

365

1417

A04AA02

ATC

granisetron; systemic, transdermal

0.3

38.8

132

3253

F00.09

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset information on additional symptoms is lacking

76.0

38.3

SPAT1172

SPAT

Guidance concerning hydration

1.9

38.3

478

2061

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

2.8

38.0

201

598

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

37.9

1767

10613

JN4AD

NOMESCO Finland

Body CT examination

0.6

37.4

646

8760

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.2

37.1

2324

WZC30

NOMESCO Finland

Teaching

0.6

37.0

793

10200

IHA21

NOMESCO Finland

Mini-intervention for hazardous and harmful alcohol use

11.1

36.6

SPAT1251

SPAT

Organisation of medication

1.8

36.6

540

2460

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

36.4

1171

6535

EB4VA, ,

NOMESCO Finland

0.4

36.2

201

3968

SPAT1229

SPAT

Assessment of need for aid

1.5

35.9

1186

6654

IHZ08

NOMESCO Finland

Provision of support and information for patient’s relatives

9.2

35.5

AA1BG, ,

SPAT

2.8

35.0

181

532

R56.8

ICD-10 Finland

Other and unspecified convulsions

1.9

34.9

486

2173

Z13.3

ICD-10 Finland

Special screening examination for mental and behavioural disorders

11.4

34.6

N02AJ06

ATC

codeine and paracetamol; systemic

0.7

34.4

2519

25916

TQW40, ,

SPAT

0.5

34.3

308

5076

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.6

33.7

813

4243

A98

ICPC

Health maint/preventive medicine

1.3

33.7

9580

73504

C03DA01

ATC

spironolactone; oral

0.7

33.5

1069

12646

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.7

33.3

943

11428

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.4

33.1

145

3170

XX3DW

NOMESCO Finland

Time consuming IT work

0.6

32.9

480

6820

KMAK, ,

NOMESCO Finland

1.3

32.9

3808

26169

F01.2

ICD-10 Finland

Subcortical vascular dementia

3.1

32.5

146

396

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.0

32.5

391

1665

C10AA01

ATC

simvastatin; oral

1.3

31.8

6320

46241

WZC00

NOMESCO Finland

Treatment plan or consultation

0.7

31.8

2267

23473

U13

ICPC

Bladder symptom/complaint other

1.9

31.7

402

1742

R4110, ,

SPAT

0.6

31.3

634

8286

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

31.2

865

4666

Z20.8

ICD-10 Finland

Contact with and exposure to other communicable diseases

2.2

30.8

264

988

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

1.7

30.7

559

2709

C10AX09

ATC

ezetimibe; oral

0.7

30.6

903

10866

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.3

30.6

2197

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

30.2

4513

31898

P29

ICPC

Psychological sympt/compl other

2.1

30.1

318

1293

-2, ,

ICPC

3.3

30.1

118

295

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

2.4

29.9

218

761

R23.8

ICD-10 Finland

Other and unspecified skin changes

0.7

29.7

1345

14962

WW200, ,

SPAT

0.7

29.5

1753

18678

M04AA01

ATC

allopurinol; systemic

0.7

29.4

1257

14125

AA1CG, ,

SPAT

3.4

29.3

110

267

WX402

NOMESCO Finland

General anaesthesia

0.7

29.3

921

10949

3310A

ICD-9 Finland

Other cerebral degenerations, Alzheimer's disease

+∞

29.0

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

2.2

28.9

242

897

A04AA01

ATC

ondansetron; systemic, rectal

0.5

28.9

295

4664

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

13.7

28.8

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.7

28.7

527

2560

Z28

ICPC

Limited function/disability (Z)

3.5

28.5

101

236

F0024, G301,

ICD-10 Finland

257.7

28.5

Z2445

NOMESCO Finland

Psychologist

2.5

28.4

188

628

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

0.6

28.2

753

9260

F009, G301,

ICD-10 Finland

+∞

28.0

A10BK03

ATC

empagliflozin; oral

0.6

27.7

483

6559

WX212

NOMESCO Finland

Femoral plexus blockade

1.9

27.7

373

1651

A27

ICPC

Fear of other disease NOS

1.6

27.1

609

3122

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.6

27.0

492

6605

F22.0

ICD-10 Finland

Delusional disorder

2.5

26.9

169

550

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.6

26.5

518

6841

SPAT1050

SPAT

Extensive neurological examination

2.1

26.3

268

1075

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

26.2

1583

R06.0

ICD-10 Finland

Dyspnoea

0.8

26.1

2451

24592

E0000UV, ,

ATC

1.2

25.9

4113

29129

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.4

25.4

103

2332

F01.29

ICD-10 Finland

Subcortical vascular dementia without information on additional symptoms

3.5

25.2

208

Z51.5

ICD-10 Finland

Palliative care

1.4

25.1

1412

8715

SPAT1276

SPAT

Outlining of treatment with patient or their family members

1.9

25.1

305

1305

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.4

25.0

100

2281

ZXA00

NOMESCO Finland

Right side

1.3

24.9

3244

22448

H02AB06

ATC

prednisolone; systemic

0.8

24.8

4199

39478

F0019, G309,

ICD-10 Finland

+∞

24.1

N17

ICPC

Vertigo/dizziness

1.3

24.0

1630

10358

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

24.0

370

1710

S00.0

ICD-10 Finland

Superficial injury of scalp

1.9

23.9

316

1390

IHZ08, ,

SPAT

3.6

23.9

188

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

1.9

23.8

335

1505

F0024, G308,

ICD-10 Finland

214.8

23.7

SDA04

NOMESCO Finland

Demanding periodontal treatment

0.7

23.7

1033

11603

SAB01

NOMESCO Finland

Restricted oral and dental health check by dental hygienist or dental assistant

1.6

23.6

554

2871

WYA20, ,

SPAT

2.8

23.4

123

366

N07AA06, ,

ATC

+∞

23.2

D12

ICPC

Constipation

1.6

23.2

517

2646

L89

ICD-10 Finland

Decubitus ulcer and pressure area

1.8

22.8

332

1508

P04

ICPC

Feeling/behaving irritable/angry

5.2

22.5

A23

ICPC

Risk factor NOS

1.5

22.4

674

3700

P05

ICPC

Senility, feeling/behaving old

2.8

22.1

116

345

XF606, ,

SPAT

2.6

21.7

131

419

W0A10

NOMESCO Finland

Mapping of psychosocial situation

5.9

21.6

GD1AD

NOMESCO Finland

Thorax CT examination

0.5

21.5

272

4035

N28

ICPC

Limited function/disability (N)

2.1

21.5

222

897

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

3.3

21.2

208

ZXA05

NOMESCO Finland

Left side

1.2

21.2

3020

21040

R1210, ,

SPAT

3.3

20.9

210

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.9

20.8

279

1234

N02AX02

ATC

tramadol; systemic, rectal

0.8

20.8

3692

34749

T03

ICPC

Loss of appetite

3.6

20.7

167

A10AB05

ATC

insulin aspart; parenteral

1.4

20.5

820

4766

WW500

NOMESCO Finland

Blood transfusion

0.5

20.3

148

2627

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

3.3

20.2

202

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.4

20.2

1024

6205

J96.1

ICD-10 Finland

Chronic respiratory failure

0.4

20.1

1945

R33

ICD-10 Finland

Retention of urine

1.3

20.1

1298

8174

Z60.8

ICD-10 Finland

Other problems related to social environment

3.8

20.0

140

L01BC06

ATC

capecitabine; oral

0.4

19.9

2046

W06

ICD-10 Finland

Fall involving bed

2.3

19.7

154

556

F05.8

ICD-10 Finland

Other delirium

2.5

19.7

131

440

SPAT1058

SPAT

PEF monitoring instruction

0.6

19.6

364

4875

XQ855, ,

SPAT

2.4

19.4

141

494

G04CB01

ATC

finasteride; oral

1.3

19.3

1935

12923

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

19.3

2318

22754

F32

ICD-10 Finland

Depressive episode

1.8

19.2

277

1256

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.3

19.1

1346

8580

TDA90, ,

SPAT

0.6

19.0

354

4737

Z73.6

ICD-10 Finland

Limitation of activities due to disability

2.6

19.0

112

355

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.7

18.9

334

1608

D07AA02

ATC

hydrocortisone; topical

1.3

18.8

1164

7280

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

0.1

18.8

870

Z71.8

ICD-10 Finland

Other specified counselling

1.2

18.7

2823

19741

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.3

18.7

142

507

WZC30, ,

SPAT

0.6

18.6

332

4488

I50.1

ICD-10 Finland

Left ventricular failure

0.6

18.5

430

5468

G31.0

ICD-10 Finland

Circumscribed brain atrophy

3.1

18.4

219

G31.1

ICD-10 Finland

Senile degeneration of brain, not elsewhere classified

5.0

18.3

N02BF01

ATC

gabapentin; oral

0.6

18.3

436

5511

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

0.2

18.3

925

F01.30

ICD-10 Finland

Mixed cortical and subcortical vascular dementia without additional symptoms

2.7

18.2

104

324

A10BK01

ATC

dapagliflozin; oral

0.6

18.2

365

4800

FN2BA

NOMESCO Finland

Percutaneous transluminal coronary angioplasty with stent (includes balloon pre-dilation)

0.6

18.2

333

4473

S01.8

ICD-10 Finland

Open wound of other parts of head

2.1

17.9

184

743

250, ,

Kela drug reimbursment

0.3

17.9

1496

C10AA07

ATC

rosuvastatin; oral

0.8

17.9

2230

21834

R11

ICD-10 Finland

Nausea and vomiting

1.4

17.8

954

5833

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.0

17.7

193

797

J01MA02

ATC

ciprofloxacin; systemic

1.2

17.6

4597

33820

I67.4

ICD-10 Finland

Hypertensive encephalopathy

6.4

17.5

ZXD35

NOMESCO Finland

Usual procedure

1.7

17.5

350

1743

SPAT1284

SPAT

Extensive health certificate

1.9

17.4

222

967

WYA30, ,

SPAT

3.2

17.4

183

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

0.7

17.4

614

7179

4289X

ICD-9 Finland

Heart failure, unspecified

0.1

17.4

527

G31.8

ICD-10 Finland

Other specified degenerative diseases of nervous system

2.7

17.4

290

R03AC02

ATC

salbutamol; inhalant

0.8

17.3

4108

37856

SPAT1307

SPAT

Psychosocial counselling and guidance

1.9

17.3

228

1005

SPAT1014

SPAT

Treatment of eyes

1.8

17.3

250

1135

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

0.2

17.3

1083

G04CA02

ATC

tamsulosin; oral

1.2

17.2

3605

25991

XF606

NOMESCO Finland

Ortostatic test

2.3

17.2

131

469

R45.1

ICD-10 Finland

Restlessness and agitation

4.5

17.1

T08

ICPC

Weight loss

2.0

17.0

202

859

F00.21

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly paranoidism

16.5

17.0

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

0.5

16.8

213

3155

WF002

NOMESCO Finland

Radical radiotherapy

0.6

16.8

250

3540

SPAT1167

SPAT

Insertion of urinary catheter

1.5

16.8

514

2833

N03AX14

ATC

levetiracetam; systemic

1.8

16.7

265

1238

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

4.1

16.6

F009, F03,

ICD-10 Finland

7.6

16.4

S28

ICPC

Limited function/disability (S)

2.5

16.4

109

367

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

0.1

16.3

483

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

0.8

16.2

1705

17040

R03AK03

ATC

[U] fenoterol and ipratropium bromide

0.7

16.2

519

6176

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.5

16.1

583

3322

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

16.1

2027

13875

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.4

16.1

1540

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

0.8

16.0

1518

15354

XQ858, ,

SPAT

2.7

16.0

265

L82

ICD-10 Finland

Seborrhoeic keratosis

0.8

16.0

1251

12953

HA1RA, ,

SPAT

0.3

15.9

1339

ZXD20

NOMESCO Finland

Day surgery

1.3

15.9

1129

7198

ZXY02

NOMESCO Finland

Neuropsychologist

4.8

15.8

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.3

15.8

961

5991

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

15.5

5042

37647

F0020, G301,

ICD-10 Finland

41.2

15.5

Z51.88

ICD-10 Finland

Other specified medical care

1.8

15.4

228

1043

Z2221

NOMESCO Finland

Medical doctor

1.2

15.3

2630

18580

L75

ICPC

Fracture: femur

1.8

15.2

225

1030

N06AX21

ATC

duloxetine; oral

1.4

15.2

839

5154

Z10.1

ICD-10 Finland

Routine general health check-up of inhabitants of institutions

6.1

15.1

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

15.1

817

5002

Y94.1

ICD-10 Finland

Accident in connection with service housing

5.8

15.1

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.3

15.0

1045

6644

L15

ICPC

Knee symptom/complaint

0.8

14.9

1598

15948

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

0.5

14.8

156

2442

Z11

ICPC

Compliance/being ill problem

2.6

14.7

263

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

1.5

14.6

521

2961

Z03

ICPC

Housing/neighbourhood problem

2.7

14.6

245

JN4BD

NOMESCO Finland

Extensive body CT

0.7

14.5

709

7848

Z75.0

ICD-10 Finland

Medical services not available in home

3.4

14.5

132

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

14.4

1620

10943

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

1.6

14.3

364

1925

F0022, G308,

ICD-10 Finland

70.1

14.3

F00.04

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms of mixed type

70.1

14.3

R54

ICD-10 Finland

Senility

2.2

14.2

117

434

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

14.1

1068

6870

WPA10, ,

SPAT

3.3

14.0

139

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

13.9

2993

21544

R2110

NOMESCO Finland

Giving the first information

1.5

13.9

471

2651

WX199

NOMESCO Finland

Other local analgesia

0.5

13.9

151

2337

R03BB04

ATC

tiotropium bromide; inhalant

0.8

13.8

896

9522

S52.5

ICD-10 Finland

Fracture of lower end of radius

1.3

13.8

1005

6430

B01AB10

ATC

tinzaparin; parenteral

0.7

13.7

571

6487

K08.3

ICD-10 Finland

Retained dental root

1.4

13.7

736

4502

P18

ICPC

Medication abuse

3.3

13.6

129

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.3

13.6

1188

7780

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.4

13.6

1360

M02AA07

ATC

piroxicam; topical

1.2

13.5

4043

29894

F0021, G301,

ICD-10 Finland

46.7

13.5

EBA30

NOMESCO Finland

Extraction of root of tooth

1.4

13.3

554

3243

S01

ICD-10 Finland

Open wound of head

2.0

13.3

140

573

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.2

13.2

109

405

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

0.6

13.2

240

3228

S32.8

ICD-10 Finland

Fracture of other and unspecified parts of lumbar spine and pelvis

1.9

13.2

172

757

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

1.8

13.2

187

846

U28

ICPC

Limited function/disability (U)

1.9

13.1

156

666

N40

ICD-10 Finland

Hyperplasia of prostate

1.2

13.1

3259

23730

F00.29

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type without information on additional symptoms

17.3

13.1

K59.0

ICD-10 Finland

Constipation

1.4

13.0

734

4521

A10BJ06

ATC

semaglutide; parenteral

0.4

13.0

1416

IHA10

NOMESCO Finland

Structured mapping of problematic alcohol use

2.7

13.0

222

L01CA04

ATC

vinorelbine; systemic

0.1

13.0

444

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.2

13.0

1716

11787

E000001, ,

ATC

1.2

13.0

1733

11918

H02AA02

ATC

fludrocortisone; oral

2.1

13.0

123

484

N06AX16

ATC

venlafaxine; oral

1.4

12.9

733

4519

ZX120

NOMESCO Finland

Intravenous

0.7

12.9

543

6164

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.0

12.9

148

624

WF003

NOMESCO Finland

Adjuvant radiotherapy

0.5

12.9

100

1730

G04BD08

ATC

solifenacin; oral

1.3

12.9

837

5267

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.2

12.9

1848

12802

F00, F03,

ICD-10 Finland

5.0

12.8

A01

ICPC

Pain general/multiple sites

1.3

12.8

1041

6756

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

0.4

12.7

1388

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

12.7

1468

TK800

NOMESCO Finland

Hemodialysis

0.3

12.6

1000

G46.8*I67.9

ICD-10 Finland

Other vascular syndromes of brain in cerebrovascular diseases

3.5

12.6

103

GD1AA

NOMESCO Finland

Thorax X-ray examination

0.9

12.6

4921

44003

F00.03

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenil onset other additional symptoms, mainly depression

+∞

12.5

S18

ICPC

Laceration/cut

0.9

12.5

4174

37756

L03AA13

ATC

pegfilgrastim; parenteral

0.5

12.4

111

1825

G03CA04

ATC

estriol; systemic, vaginal

1.3

12.4

1055

6888

S09.9

ICD-10 Finland

Unspecified injury of head

1.8

12.3

177

804

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

0.7

12.3

439

5126

C04AE01

ATC

ergoloid mesylates; systemic

2.1

12.3

119

472

IAB14

NOMESCO Finland

Geriatric psychiatry consultation

3.8

12.2

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.2

12.1

1696

11711

A08.1

ICD-10 Finland

Acute gastroenteropathy due to Norovirus

2.8

12.0

180

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

0.3

11.9

945

R44.3

ICD-10 Finland

Hallucinations, unspecified

2.5

11.8

248

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.2

11.8

649

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

4.6

11.8

G47.3

ICD-10 Finland

Sleep apnoea

0.8

11.7

1032

10556

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

1.8

11.7

173

794

XA400

NOMESCO Finland

EEG

2.7

11.7

192

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.5

11.7

113

1811

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.4

11.7

480

2806

Z02.8

ICD-10 Finland

Other examinations for administrative purposes

2.5

11.7

240

I50.0

ICD-10 Finland

Congestive heart failure

0.8

11.6

1071

10901

2900A

ICD-9 Finland

Senile and presenile organic psychotic conditions, Senile dementia, uncomplicated

3.4

11.6

105

F0014, G309,

ICD-10 Finland

+∞

11.6

F009, G308,

ICD-10 Finland

+∞

11.6

F0001, G300,

ICD-10 Finland

+∞

11.6

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

0.6

11.6

236

3086

F0001, G301,

ICD-10 Finland

57.7

11.5

E66.01

ICD-10 Finland

Obesity due to excess calories

0.6

11.5

145

2144

D82

ICPC

Teeth/gum disease

0.8

11.5

1706

16511

L08

ICPC

Shoulder symptom/complaint

0.8

11.4

1443

14193

P28

ICPC

Limited function/disability (P)

2.8

11.4

176

NFB10

NOMESCO Finland

Primary partial prosthetic replacement of hip joint not using cement, other or unspecified

2.5

11.4

233

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.3

11.4

700

4372

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

1.8

11.4

183

862

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

0.3

11.3

793

L03AA02

ATC

filgrastim; parenteral

0.4

11.3

1358

T05

ICPC

Feeding problem of adult

2.6

11.3

210

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.7

11.3

295

3653

N07

ICPC

Convulsion/seizure

4.4

11.3

S72.9

ICD-10 Finland

Fracture of femur, part unspecified

2.3

11.2

300

F00.23

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type of other additional symptoms, mainly depression

20.0

11.2

A11CC03

ATC

alfacalcidol; systemic

0.5

11.1

1441

F00.0

ICD-10 Finland

Dementia in Alzheimer disease with early onset

30.9

11.1

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

2.2

11.1

376

L57.0

ICD-10 Finland

Actinic keratosis

0.8

11.0

1159

11626

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.9

11.0

143

R01AD58

ATC

fluticasone, combinations; nasal

0.8

11.0

746

7889

SPAT1312

SPAT

General health counselling

0.8

11.0

2236

21060

Y94.0

ICD-10 Finland

Accident at home

1.7

11.0

221

1107

N43

ICPC

Neurological, Other diagnostic procedure

2.5

11.0

218

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.5

11.0

129

1945

Z60.9

ICD-10 Finland

Problem related to social environment, unspecified

3.1

10.9

122

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

0.4

10.8

1279

SPAT1236

SPAT

Informing family of child’s disability

1.7

10.8

194

943

OAA67, ,

SPAT

1.8

10.8

146

653

L13

ICPC

Hip symptom/complaint

0.8

10.7

1518

14774

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.4

10.7

1089

A78

ICPC

Infectious disease other/NOS

2.1

10.7

103

409

WX722

NOMESCO Finland

PEEP

0.6

10.7

195

2615

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.2

10.7

1992

14125

F00.02

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset other additional symptoms, mainly illusions

53.5

10.6

F0010, G308,

ICD-10 Finland

+∞

10.6

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.6

10.6

263

1387

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

0.4

10.6

962

J01.0

ICD-10 Finland

Acute maxillary sinusitis

0.8

10.6

896

9212

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

0.2

10.6

669

N05AX12

ATC

aripiprazole; systemic

2.2

10.5

330

N04BD02

ATC

rasagiline; oral

0.2

10.5

404

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.2

10.5

1737

12186

S82

ICPC

Naevus/mole

0.8

10.4

740

7779

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.2

10.4

1483

10250

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

0.3

10.4

819

A12AA04

ATC

calcium carbonate; oral

0.3

10.4

893

DAX08

NOMESCO Finland

Fitting of hearing aid

0.7

10.4

487

5428

T11

ICPC

Dehydration

3.7

10.3

K59.09

ICD-10 Finland

Constipation, unspecified

1.3

10.3

842

5471

G31.9

ICD-10 Finland

Degenerative disease of nervous system, unspecified

3.0

10.2

127

R18

ICD-10 Finland

Ascites

0.4

10.2

1124

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

10.2

3128

23063

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

2.7

10.2

168

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

0.2

10.1

612

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.7

10.1

169

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.1

10.0

3755

28072

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.8

10.0

1564

15089

H25.1

ICD-10 Finland

Senile nuclear cataract

1.1

10.0

4986

37976

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.3

10.0

655

4129

4402A

ICD-9 Finland

Atherosclerosis, Of native arteries of the extremities

0.4

10.0

1113

A04AA55

ATC

palonosetron, combinations; systemic

0.3

10.0

801

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

0.5

9.9

1525

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

3.4

9.9

R32

ICD-10 Finland

Unspecified urinary incontinence

1.5

9.9

338

1910

R03BA08

ATC

ciclesonide; inhalant

0.7

9.9

331

3905

R4110

NOMESCO Finland

Physiotherapy

1.2

9.8

2746

20103

SAA01

NOMESCO Finland

Simple examination of mouth

1.1

9.8

5371

41137

Z08

ICPC

Social welfare problem

2.1

9.8

368

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

0.7

9.7

278

3381

R01AD59

ATC

mometasone, combinations; nasal

0.4

9.7

1078

R63.4

ICD-10 Finland

Abnormal weight loss

1.4

9.7

441

2627

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.5

9.7

327

1844

A69.2

ICD-10 Finland

Lyme disease

0.6

9.7

230

2904

F0004, G300,

ICD-10 Finland

+∞

9.7

F0023, G308,

ICD-10 Finland

+∞

9.7

R45.5

ICD-10 Finland

Hostility

9.2

9.6

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.5

9.6

340

1937

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.4

9.5

508

3105

L90

ICPC

Osteoarthrosis of knee

0.7

9.5

417

4700

WF004

NOMESCO Finland

Palliative radiotherapy

0.5

9.5

1372

D10

ICPC

Vomiting

1.6

9.5

227

1188

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.5

9.4

1498

4148X

ICD-9 Finland

Other forms of chronic ischaemic heart disease, Other specified forms of chronic ischaemic heart disease[MORBUS CORDIS ISCHAEMICUS ALIA,MÄÄRITTELEMÄT]

0.3

9.4

789

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

9.4

1512

10575

WVA30, ,

SPAT

0.7

9.4

311

3673

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.4

9.3

990

ZX080

NOMESCO Finland

Image guided radiotherapy

0.4

9.3

894

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

9.3

1007

10074

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

1.6

9.3

216

1124

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

0.6

9.3

201

2586

N18.8

ICD-10 Finland

Other chronic renal failure

0.6

9.2

145

2016

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

0.4

9.2

888

S32.5

ICD-10 Finland

Fracture of pubis

1.8

9.2

138

639

N05CD07

ATC

temazepam; oral

1.2

9.2

1654

11683

L03AA14

ATC

lipegfilgrastim; parenteral

0.2

9.1

559

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

0.1

9.1

283

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

0.2

9.1

544

TPH07

NOMESCO Finland

Cathetrisation of artery

0.8

9.1

864

8770

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

0.4

9.1

1014

G04BD07

ATC

tolterodine; oral

1.3

9.1

654

4178

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

0.6

9.1

202

2585

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

0.4

9.1

1024

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

0.2

9.1

501

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.4

9.0

451

2729

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

0.7

9.0

470

5157

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.4

9.0

335

1925

PD5AD

NOMESCO Finland

CT of aorta

0.5

9.0

102

1553

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

0.2

9.0

541

Z71.9

ICD-10 Finland

Counselling, unspecified

1.3

9.0

627

3987

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.6

9.0

195

998

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

0.7

9.0

236

2915

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.8

9.0

1197

11726

N30

ICD-10 Finland

Cystitis

1.3

8.9

655

4195

C02AC05

ATC

moxonidine; oral

0.7

8.9

288

3418

D11

ICPC

Diarrhoea

1.3

8.9

779

5104

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

8.9

2525

18490

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

2.2

8.9

289

S00.8

ICD-10 Finland

Superficial injury of other parts of head

1.7

8.8

165

813

R03DA04

ATC

theophylline; systemic, rectal

0.8

8.8

521

5608

M70.6

ICD-10 Finland

Trochanteric bursitis

0.8

8.8

895

9013

R03BB01

ATC

ipratropium bromide; inhalant

0.7

8.8

378

4268

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.5

8.7

173

F000, G300,

ICD-10 Finland

+∞

8.7

F0009, G309,

ICD-10 Finland

+∞

8.7

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

1.5

8.7

251

1373

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

1.6

8.7

193

995

XF600, ,

SPAT

1.4

8.7

382

2266

R02

ICPC

Shortness of breath/dyspnoea

0.8

8.6

1109

10908

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.7

8.6

222

2754

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.6

8.6

118

1700

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

0.4

8.6

850

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

1.5

8.6

269

1497

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.3

8.6

576

3647

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

1.9

8.5

100

428

A10AE04

ATC

insulin glargine; parenteral

1.2

8.5

960

6475

F00.22

ICD-10 Finland

Dementia in Alzheimer's disease, atypical or mixed type other additional symptoms, mainly hallucinations

8.7

8.5

F0022, G301,

ICD-10 Finland

24.7

8.5

JN3AD

NOMESCO Finland

Abdominal CT examination

0.8

8.5

869

8747

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

0.5

8.4

1360

N18.0

ICD-10 Finland

End-stage renal disease

0.3

8.4

684

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.2

8.4

269

S42.0

ICD-10 Finland

Fracture of clavicle

1.6

8.4

215

1146

HA1AA

NOMESCO Finland

X-ray mammography

0.7

8.4

361

4075

4120X

ICD-9 Finland

Old myocardial infarction[STATUS POST INFARCTUM CORDIS,MÄÄRITTELEMÄT]

0.5

8.4

1485

C08CA13

ATC

lercanidipine; oral

0.8

8.4

1329

12815

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.2

8.3

1180

8149

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

0.8

8.3

955

9499

128

Kela drug reimbursment

Cancers of female genital organs

0.4

8.3

826

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.3

8.3

630

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

0.5

8.3

1078

G72.8

ICD-10 Finland

Other specified myopathies

1.6

8.3

199

1045

XX2RW, ,

NOMESCO Finland

0.2

8.3

525

D06BB10

ATC

imiquimod; topical

0.7

8.3

309

3571

H02BX01

ATC

methylprednisolone, combinations; systemic

1.3

8.3

628

4043

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.3

8.3

208

Z74.1

ICD-10 Finland

Need for assistance with personal care

7.5

8.2

XCH00

NOMESCO Finland

Eye pressure measurement

0.7

8.2

304

3519

F0021, G308,

ICD-10 Finland

30.2

8.2

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

0.7

8.2

297

3449

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

0.8

8.2

503

5385

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

0.7

8.1

352

3971

D70.82

ICD-10 Finland

Drug-induced neutropenia

0.3

8.1

635

H25.8

ICD-10 Finland

Other senile cataract

0.8

8.1

1408

13474

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

0.6

8.1

135

1846

F01.34

ICD-10 Finland

Mixed cortical and subcortical vascular dementia are other mixed symptoms of mixed type

3.8

8.1

S01BC05

ATC

ketorolac; ophthalmic

1.3

8.1

569

3625

TFP20

NOMESCO Finland

Cardiodefibrillation

0.8

8.1

579

6078

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

8.1

419

AA1AA

NOMESCO Finland

Head X-ray examination

2.0

8.1

362

A01AB09

ATC

miconazole; local oral

1.2

8.0

903

6089

N29

ICPC

Neurological sympt/complt other

1.6

8.0

176

905

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

0.2

8.0

307

Z27

ICPC

Fear of a social problem

3.0

8.0

100

F32.0

ICD-10 Finland

Mild depressive episode

1.7

8.0

133

636

K86

ICPC

Hypertension uncomplicated

0.8

8.0

1183

11480

SPAT1043

SPAT

Audiometry

0.8

8.0

918

9128

D51.9

ICD-10 Finland

Vitamin B12deficiency anaemia, unspecified

1.6

8.0

160

805

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

0.5

7.9

1385

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

2.5

7.9

157

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

1.4

7.9

287

1646

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

0.4

7.9

853

S00.9

ICD-10 Finland

Superficial injury of head, part unspecified

1.7

7.9

130

620

IBZ07

NOMESCO Finland

Neurological assessment in psychiatry

3.5

7.9

HA1AA, ,

SPAT

0.4

7.9

817

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

0.7

7.9

429

4670

A10AE05

ATC

insulin detemir; parenteral

1.3

7.8

461

2864

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

0.5

7.8

1253

N02BF02

ATC

pregabalin; oral

0.7

7.8

266

3126

193

Kela drug reimbursment

Rasagiline

0.2

7.8

306

D07AB02

ATC

hydrocortisone butyrate; topical

1.1

7.8

2678

19844

C45.0

ICD-10 Finland

Mesothelioma of pleura

0.0

7.8

191

ZX120, ,

SPAT

1.7

7.8

134

646

N05AL01

ATC

sulpiride; systemic

1.8

7.8

121

567

NK6AN

NOMESCO Finland

Total body bone isotope imaging

0.6

7.8

126

1734

N80

ICPC

Head injury other

1.6

7.8

185

970

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

0.6

7.8

172

2200

62670

ICD-8 Finland

Disorders of menstruation, Postmenopausal bleeding

1.7

7.8

126

598

SPAT1377

SPAT

Polysomnography

0.5

7.8

1007

SPAT1313

SPAT

Guidance and counselling related to accident prevention

2.1

7.8

300

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

0.3

7.7

619

N99

ICPC

Neurological disease other

1.8

7.7

111

508

F0023, G301,

ICD-10 Finland

74.1

7.7

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

0.7

7.7

427

4639

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

2.4

7.7

189

M96.6

ICD-10 Finland

Fracture of bone following insertion of orthopaedic implant, joint prosthesis, or bone plate

2.0

7.7

329

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.4

7.7

315

1847

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

0.2

7.7

266

Z51.0

ICD-10 Finland

Radiotherapy session

0.4

7.7

701

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

1.3

7.6

444

2755

Z74.2

ICD-10 Finland

Need for assistance at home and no other household member able to render care

4.3

7.6

N05AB03

ATC

perphenazine; systemic, rectal

1.5

7.6

215

1172

E53.8

ICD-10 Finland

Deficiency of other specified B group vitamins

2.0

7.6

319

EBA00

NOMESCO Finland

Extraction of tooth

1.1

7.6

2806

20890

F00.2

ICD-10 Finland

Dementia in Alzheimer disease, atypical or mixed type

7.8

7.6

P03

ICPC

Feeling depressed

1.4

7.6

351

2101

R4135

NOMESCO Finland

Rehabilitation for hearing problems

0.6

7.6

127

1732

QDB10, ,

SPAT

0.6

7.6

107

1525

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.3

7.6

746

4959

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

1.6

7.5

159

810

S16

ICPC

Bruise/contusion

1.4

7.5

353

2117

T90.5

ICD-10 Finland

Sequelae of intracranial injury

2.0

7.5

298

Z29.8

ICD-10 Finland

Other specified prophylactic measures

1.7

7.5

141

697

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

0.1

7.5

203

S06.3

ICD-10 Finland

Focal brain injury

1.7

7.5

129

623

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

0.4

7.5

777

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

0.6

7.5

105

1499

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.4

7.5

278

1602

Z3226

NOMESCO Finland

Physiotherapist

1.2

7.5

1748

12604

ZXD10

NOMESCO Finland

Scheduled procedure

1.1

7.5

3900

29647

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

0.3

7.4

478

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

0.7

7.4

403

4390

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

0.4

7.4

750

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

0.8

7.4

1126

10905

TNC33

NOMESCO Finland

Custom moulded brace, elbow or forearm

3.3

7.4

ZYY02, ,

SPAT

6.3

7.4

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

7.4

103

1471

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

0.6

7.4

102

1460

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

0.7

7.4

258

3012

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

0.6

7.3

171

2161

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

0.4

7.3

687

WZC15, ,

NOMESCO Finland

0.2

7.3

308

Z00.8

ICD-10 Finland

Other general examinations

1.3

7.3

635

4162

L03

ICPC

Low back symptom/complaint

0.9

7.2

1903

17644

C01AA05

ATC

digoxin; systemic

0.8

7.2

1215

11665

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

0.6

7.2

163

2074

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

0.1

7.2

237

SPAT1125

SPAT

Stoma care and guidance

1.5

7.2

235

1321

J01CA04

ATC

amoxicillin; systemic

1.1

7.2

7715

60897

SPAT1285

SPAT

Provision of consultation response

1.3

7.2

478

3026

S22.3

ICD-10 Finland

Fracture of rib

1.3

7.2

671

4435

A05

ICPC

Feeling ill

1.4

7.2

354

2143

SPA02

NOMESCO Finland

Preparation for dental prosthetics

0.6

7.2

102

1449

SPAT1263

SPAT

Sampling

1.1

7.1

4125

31513

H04AA01

ATC

glucagon; nasal, parenteral

2.0

7.1

316

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

0.7

7.1

194

2373

SDA03

NOMESCO Finland

Periodontal treatment

0.9

7.1

2011

18552

C09CA06

ATC

candesartan; oral

0.9

7.1

1701

15878

R03AK08

ATC

formoterol and beclometasone; inhalant

0.6

7.1

147

1905

G91.0

ICD-10 Finland

Communicating hydrocephalus

2.2

7.1

207

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

0.8

7.1

451

4804

OAB71, ,

SPAT

0.2

7.1

315

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

0.4

7.1

815

WX210

NOMESCO Finland

Plexus blockade of nervus ichiadicus

2.4

7.1

166

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

0.7

7.0

251

2921

Z49.2

ICD-10 Finland

Other dialysis

0.1

7.0

234

I95.9

ICD-10 Finland

Hypotension, unspecified

1.5

7.0

185

994

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

7.0

537

3462

L02BG06

ATC

exemestane; oral

0.4

7.0

720

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.3

7.0

487

S01.9

ICD-10 Finland

Open wound of head, part unspecified

1.6

7.0

167

878

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

0.8

7.0

435

4648

197

Kela drug reimbursment

Sunitinib

0.0

7.0

170

WX302

NOMESCO Finland

Thoracal epidural anesthesy

0.7

7.0

251

2917

K02.0

ICD-10 Finland

Caries limited to enamel

0.8

7.0

564

5830

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

0.3

6.9

445

137

Kela drug reimbursment

Uraemia requiring dialysis

0.2

6.9

312

M02AA15

ATC

diclofenac; topical

1.3

6.9

642

4240

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

2.3

6.9

178

M80.0

ICD-10 Finland

Postmenopausal osteoporosis with pathological fracture

1.4

6.9

290

1710

S52.6

ICD-10 Finland

Fracture of lower end of both ulna and radius

1.5

6.9

176

940

GD1AA, ,

SPAT

0.8

6.9

434

4629

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

0.7

6.9

339

3744

PJA12

NOMESCO Finland

Sentinel node biopsy

0.7

6.9

372

4052

C10AA02

ATC

lovastatin; oral

1.3

6.9

597

3913

EP1AE

NOMESCO Finland

Neck ultrasound examination

0.7

6.8

268

3067

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

0.3

6.8

466

DFF00, ,

SPAT

0.4

6.8

699

S15

ICPC

Foreign body in skin

0.7

6.8

348

3821

S52.0

ICD-10 Finland

Fracture of upper end of ulna

1.6

6.8

140

711

Y94.8

ICD-10 Finland

Other leisure activity accident

1.5

6.8

204

1129

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

0.5

6.8

1153

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

2.7

6.8

115

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

0.8

6.8

964

9391

-, ,

ICD-10 Finland

1.5

6.8

220

1237

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

3.2

6.8

F0009, G301,

ICD-10 Finland

+∞

6.8

S01EX03, ,

ATC

1.4

6.7

337

2045

SPAT1157

SPAT

Guidance concerning treatment of mouth and mucous membranes

1.7

6.7

130

649

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.2

6.7

919

6326

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

0.7

6.7

270

3076

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.2

6.7

1017

7072

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

0.3

6.7

421

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

0.7

6.7

366

3978

B03XA02

ATC

darbepoetin alfa; parenteral

0.6

6.7

1326

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

0.6

6.6

1210

JN4CD

NOMESCO Finland

Very extensive body CT

0.7

6.6

196

2359

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

0.6

6.6

128

1683

SPAT1111

SPAT

Planning of analgesia

1.7

6.6

112

540

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

2.1

6.6

219

I48.2

ICD-10 Finland

Chronic atrial fibrillation

0.8

6.6

438

4638

R40.2

ICD-10 Finland

Coma, unspecified

1.8

6.6

455

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.8

6.6

660

6658

N04BA03

ATC

levodopa, decarboxylase inhibitor and COMT inhibitor; oral

0.4

6.6

677

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

0.5

6.6

992

N04BD01

ATC

selegiline; oral

0.5

6.6

980

A57

ICPC

General and Unspecified, Physical medicine/rehabilitation

3.8

6.6

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

3.8

6.6

Z01.7

ICD-10 Finland

Laboratory examination

1.2

6.5

1332

9497

T82

ICPC

Obesity

0.4

6.5

710

F30.1

ICD-10 Finland

Mania without psychotic symptoms

6.1

6.5

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.2

6.5

1332

9498

N39.9

ICD-10 Finland

Disorder of urinary system, unspecified

1.5

6.5

187

1025

HMAK, ,

NOMESCO Finland

0.8

6.5

441

4659

R06AE07

ATC

cetirizine; oral

1.1

6.5

3419

25958

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

0.4

6.5

589

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

0.3

6.5

413

N18.3

ICD-10 Finland

Chronic kidney disease, stage 3

0.6

6.5

104

1429

JN6AD

NOMESCO Finland

CT of torso and neck

0.4

6.5

752

D07AB08

ATC

desonide; topical

1.2

6.5

919

6351

L84

ICD-10 Finland

Corns and callosities

1.4

6.4

311

1878

180

Kela drug reimbursment

Interferon alfa

0.1

6.4

200

JAH00

NOMESCO Finland

Laparotomy

0.6

6.4

134

1732

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

0.4

6.4

563

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

0.3

6.4

488

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

0.5

6.4

784

OAB44, ,

SPAT

0.8

6.4

357

3870

CS434

NOMESCO Finland

Visual field testing with Humphrey automated perimetry

0.6

6.4

1363

I71.3

ICD-10 Finland

Abdominal aortic aneurysm, ruptured

0.4

6.4

725

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

0.8

6.4

349

3792

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

1.8

6.4

406

R96

ICPC

Asthma

0.8

6.3

559

5719

SPAT1059

SPAT

Spirometry at the office

0.7

6.3

249

2847

M75.1

ICD-10 Finland

Rotator cuff syndrome

0.9

6.3

1644

15265

L01AX03

ATC

temozolomide; systemic

0.1

6.3

157

L86

ICPC

Back syndrome with radiating pain

0.7

6.3

299

3317

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.3

6.3

529

3455

G04BD10

ATC

darifenacin; oral

1.8

6.3

384

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

0.7

6.3

263

2975

103

Kela drug reimbursment

Diabetes, insulin-treated

0.9

6.3

2767

24852

D01AE16

ATC

amorolfine; topical

1.2

6.3

1127

7954

P76

ICPC

Depressive disorder

1.4

6.3

220

1257

NG2AA

NOMESCO Finland

Patella X-ray examination

0.6

6.3

115

1529

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.7

6.3

223

2592

GD1QA, ,

SPAT

2.5

6.3

120

L02BB04

ATC

enzalutamide; oral

0.4

6.2

626

G40

ICD-10 Finland

Epilepsy

2.1

6.2

208

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

1.6

6.2

148

779

D07CC01

ATC

betamethasone and antibiotics; topical

1.2

6.2

961

6693

I42.0

ICD-10 Finland

Dilated cardiomyopathy

0.6

6.2

127

1647

SPAT1042

SPAT

Guidance concerning balance maintenance

2.0

6.2

275

N02AJ13

ATC

tramadol and paracetamol; systemic

0.5

6.2

972

F02.09*G31.0

ICD-10 Finland

Dementia in Pick's disease without information on additional symptoms

3.7

6.2

UDC00

NOMESCO Finland

Ear microscopy

0.8

6.2

418

4414

UJF30

NOMESCO Finland

Ileoscopy through colon

0.8

6.2

561

5719

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.4

6.2

316

1927

B81

ICPC

Anaemia vit B12/folate deficiency

1.3

6.2

455

2923

WVA40, ,

SPAT

2.0

6.1

276

WX882

NOMESCO Finland

High dependency care

0.6

6.1

113

1501

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

0.2

6.1

373

S20.2

ICD-10 Finland

Contusion of thorax

1.3

6.1

425

2709

TGC00

NOMESCO Finland

Bronchial lavation

0.6

6.1

103

1398

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.5

6.1

192

1074

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

0.8

6.1

768

7567

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

0.6

6.1

114

1508

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

6.1

321

1967

205

Kela drug reimbursment

Chronic hypertension

0.9

6.1

3670

32421

XQ848

NOMESCO Finland

Dermatological photography

0.6

6.1

139

1758

ZX070

NOMESCO Finland

Intensity modified radiotherapy

0.5

6.1

889

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

1.4

6.0

253

1493

R44.1

ICD-10 Finland

Visual hallucinations

1.9

6.0

318

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

0.2

6.0

261

R44.0

ICD-10 Finland

Auditory hallucinations

2.3

6.0

163

QXB99, ,

SPAT

0.6

6.0

1341

207

Kela drug reimbursment

Chronic arrhythmias

0.9

6.0

2085

19004

TFP34

NOMESCO Finland

Electrophysiological investigation

0.5

6.0

1027

U70

ICPC

Pyelonephritis/pyelitis

1.6

6.0

127

650

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

568

367

13.30

307.65

1.0

428.47

274.77

ng/l

17.50

428

214

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

572

367

13.39

307.65

1.0

562.22

772.80

ng/l

11.95

422

207

(3019309) Folate [Moles/volume] in Red Blood Cells

4642

21354

2.26

307.65

1.9

1.8

1171.58

1151.19

nmol/l

0.73

3392

15744

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

572

366

13.43

307.65

1.0

56.49

34.85

ng/l

15.92

428

210

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4074

20940

1.89

214.95

3.1

2.46

2.47

mmol/l

10.38

3678

18386

(3021960) Folate [Moles/volume] in Serum or Plasma

5357

30629

1.77

194.64

2.0

1.8

20.60

20.17

nmol/l

1.07

4826

25383

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6971

43325

1.74

185.34

2.8

2.4

91.82

93.73

pmol/l

2.67

3779

22766

(3015377) Calcium [Moles/volume] in Serum or Plasma

5455

32586

1.67

158.32

2.7

3.4

2.35

mmol/l

0.90

4902

28806

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

583

1414

3.51

155.01

1.2

1.3

492.50

622.08

mg/l

4.59

523

1355

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

516

1190

3.68

147.68

1.3

1.4

384.67

1249.30

e6/l

2.92

384

970

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

513

1180

3.69

147.37

1.2

1.4

6.30

30.39

e6/l

2.53

374

900

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

517

1222

3.59

142.72

1.2

3.86

3.87

mmol/l

0.11

484

1141

(3031040) Bacteria [#/volume] in Urine by Automated count

8394

57785

1.60

121.21

6.5

6.1

2989.11

2159.57

e6/l

0.56

224

953

(3009466) Valproate [Moles/volume] in Serum or Plasma

371

790

3.95

118.54

3.1

3.7

303.19

320.62

umol/l

1.36

305

651

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2535

13467

1.69

105.98

2.0

1.9

—

(3023410) Appearance of Cerebral spinal fluid

263

479

4.59

102.51

1.3

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4942

30948

1.52

102.29

2.5

2.2

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

7737

53282

1.52

100.78

29.8

30.7

329.40

329.68

g/l

1.92

7623

52792

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2645

14591

1.62

93.96

2.0

1.9

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

6495

43627

1.47

91.33

4.0

4.8

34.58

33.94

g/l

16.97

5916

40205

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

5615

36762

1.47

89.25

2.3

2.4

78.17

81.47

nmol/l

13.51

4956

31607

(3020682) Albumin/Creatinine [Ratio] in Urine

2822

32040

0.64

85.92

3.4

4.2

9.42

10.04

mg/mmol

0.26

1794

20045

(3012516) Albumin [Mass/volume] in Urine

2713

31042

0.64

85.54

2.9

3.4

60.00

53.14

mg/l

0.41

1775

20182

(3009508) Creatinine [Moles/volume] in Urine

2728

31135

0.64

84.79

2.8

3.4

6.94

6.54

mmol/l

5.87

2261

25312

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3288

19508

1.53

83.53

2.0

—

(3026008) Bacteria identified in Urine by Culture

5277

34472

1.45

82.59

4.0

—

(3018418) pH of Serum or Plasma

4701

30058

1.46

82.24

3.2

4.3

7.40

4.61

3340

21984

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6497

44541

1.42

75.30

4.8

6.5

1.22

1.21

mmol/l

12.68

5900

40533

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2350

26876

0.65

70.16

1.7

1.9

1.18

1.24

mmol/l

4.46

2088

21339

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

9659

72080

1.46

62.56

21.9

22.7

32.27

29.38

mg/l

11.89

8610

62989

(3023368) Bacteria identified in Blood by Culture

4672

31327

1.36

55.27

4.1

4.5

—

(3019150) Specific gravity of Urine by Refractometry

3071

19317

1.41

53.06

5.3

5.2

1.02

1.17

kg/l

0.80

2079

13407

(3011397) Hemoglobin [Presence] in Urine by Test strip

3295

21015

1.39

52.39

4.5

0.17

0.30

0.35

360

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6961

49863

1.34

51.74

5.4

7.2

1.22

1.21

mmol/l

30.00

6032

42283

(40768804) Tissue Pathology biopsy report

3048

31799

0.72

50.34

2.3

2.5

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3281

21134

1.38

48.37

1.9

1.8

443.24

24661444.43

pmol/l

11.10

2658

16593

(3016018) Differential panel - Cerebral spinal fluid

224

618

3.02

48.30

1.2

1.3

—

(3010813) Leukocytes [#/volume] in Blood

9880

75019

1.41

48.18

31.5

34.2

7.19

7.13

e9/l

0.81

9520

72570

(3035941) MCH [Entitic mass]

9875

75003

1.40

47.79

31.4

34.1

30.41

30.42

0.02

9640

73703

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

9875

75005

1.40

47.76

31.9

34.7

38.16

38.58

10.52

9634

73664

(3026361) Erythrocytes [#/volume] in Blood

9875

75006

1.40

47.74

31.4

34.2

4.22

4.27

e12/l

20.15

9502

72530

(3024731) MCV [Entitic mean volume] in Red Blood Cells

9875

75007

1.40

47.73

31.4

34.1

92.11

92.13

0.14

9641

73709

(3007461) Platelets [#/volume] in Blood

9874

75002

1.40

47.67

31.5

34.2

235.18

236.41

e9/l

1.02

9522

72901

(3000963) Hemoglobin [Mass/volume] in Blood

9875

75012

1.40

47.66

31.7

34.5

127.04

128.77

g/l

26.28

9642

73754

(3019550) Sodium [Moles/volume] in Serum or Plasma

9838

74695

1.40

47.49

27.1

28.4

139.71

139.36

mmol/l

24.38

9588

73068

(3023103) Potassium [Moles/volume] in Serum or Plasma

9842

74731

1.40

47.49

27.2

28.7

4.00

4.02

mmol/l

11.98

9583

73015

(3013512) EKG study

3244

33279

0.73

47.21

4.2

4.6

1.00

0.72

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

9860

74951

1.40

46.66

28.5

31.0

85.56

88.65

umol/l

14.32

9617

73636

(3037467) Urinalysis macro (dipstick) panel - Urine

7779

57173

1.32

44.87

5.5

5.6

2.63

134.88

0.49

100

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

8852

66374

1.34

43.66

5.5

5.7

2.02

2.13

mu/l

9.28

8039

59207

(3002179) Metamyelocytes/Leukocytes in Blood

528

7780

0.54

41.55

3.0

3.8

0.66

0.69

0.09

152

2601

(3021440) Promyelocytes/Leukocytes in Blood

544

7914

0.55

40.94

3.3

3.9

0.11

0.10

0.12

143

2442

(3017181) Myelocytes/Leukocytes in Blood

582

8275

0.56

40.37

3.2

3.9

0.91

0.92

0.03

179

2782

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2550

16204

1.37

39.53

3.4

3.5

2.69

2.72

e6/l

0.05

1276

8504

(1761868) Lipid panel - Serum or Plasma

1548

17479

0.69

38.54

3.2

4.0

—

(3025159) Blasts/Leukocytes in Blood

548

7802

0.56

38.08

3.3

4.0

0.16

0.42

1.45

135

2246

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

860

10918

0.62

37.99

1.2

1.3

14.91

15.65

u/ml

0.08

210

3546

(3015736) pH of Urine

5047

35496

1.29

37.75

4.2

6.33

6.35

0.42

2459

18805

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

7472

55213

1.28

37.57

4.0

4.5

15.23

15.33

pmol/l

2.63

6648

48785

(4035726) Immunohistochemistry procedure

589

8030

0.58

34.66

1.2

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4127

28686

1.27

32.41

2.4

2.5

2.80

3.10

mg/l

12.74

3475

24462

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2666

17544

1.32

31.67

3.3

3.4

1.45

1.40

e6/l

0.09

1408

9864

(3035350) Ketones [Presence] in Urine by Test strip

6046

44157

1.25

30.30

4.7

4.8

6.57

2.77

estimate

0.57

1027

10265

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2984

20041

1.30

30.28

4.5

4.7

199.49

423.79

ng/l

3.99

2735

18128

(3037522) Nuclear Ab [Titer] in Serum

709

8939

0.63

29.88

1.3

440.28

504.97

titre

0.68

145

2200

(40760892) CBC W Ordered Manual Differential panel - Blood

1394

15370

0.71

29.14

3.7

4.8

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1009

11596

0.69

26.59

1.2

1.3

41.21

44.73

iu/ml

0.26

306

3478

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

4895

35260

1.23

26.51

3.7

3.8

—

2.34

—

(3021601) Nitrite [Presence] in Urine by Test strip

5918

43549

1.23

25.89

4.7

4.8

0.00

estimate

0.12

951

9838

(3009261) Glucose [Presence] in Urine by Test strip

6026

44458

1.22

25.57

4.7

4.9

1.06

0.47

estimate

0.24

965

9644

(36304419) Bacteria [Presence] in Urine

3719

26103

1.25

25.24

3.7

41.11

123.79

estimate

0.48

192

(3013826) Glucose [Moles/volume] in Serum or Plasma

7038

52820

1.22

24.93

4.6

5.2

7.01

6.92

mmol/l

2.22

6699

50470

(3026493) Urate [Moles/volume] in Serum or Plasma

2274

22868

0.78

24.31

2.4

3.1

354.39

368.20

umol/l

7.05

1859

19163

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

940

10720

0.70

23.50

4.6

5.5

34.58

34.49

0.08

539

6647

(3018095) Leukocytes [#/volume] in Urine

4813

34902

1.22

23.49

4.7

4.5

162.48

145.90

e6/l

0.35

3371

25788

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

481

6286

0.61

23.49

1.3

1.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4223

30224

1.23

23.45

2.3

2.2

269.54

223.33

u/l

2.12

3938

28263

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

7303

55227

1.21

22.97

27.9

28.3

14.04

14.16

10.56

7209

54399

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

697

3835

1.52

22.88

1.2

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

303

1344

1.88

22.39

1.1

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

175

633

2.29

22.27

2.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

314

4488

0.56

21.80

2.1

1.9

2.07

1.41

g/l

1.23

256

3994

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

477

2466

1.62

20.54

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

477

2466

1.62

20.54

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

3061

21487

1.23

19.73

3.4

3.8

0.17

0.08

1.01

118

971

(3002582) Erythrocytes [#/volume] in Urine

4433

32331

1.20

19.15

3.8

92.98

109.48

e6/l

0.43

3348

25333

(3005719) IgG [Mass/volume] in Serum or Plasma

438

5584

0.63

19.12

3.0

2.8

10.72

10.80

g/l

0.11

382

5073

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

486

6031

0.65

18.71

1.3

—

(3003694) ABO and Rh group [Type] in Blood

1866

18630

0.79

17.84

1.2

1.3

—

(3022145) Colonoscopy Study observation

796

8889

0.72

17.27

1.3

—

(3002256) Pathology report gross observation

1103

11714

0.75

17.12

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

248

3510

0.57

16.61

2.5

4.3

156.88

98.58

u/ml

0.74

234

3358

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

670

3904

1.44

16.49

1.4

1.5

1.67

1.66

0.15

548

3064

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

593

6861

0.70

15.83

2.8

3.0

55.35

55.05

ml/min/173m2

0.10

248

3300

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

232

2.78

15.02

1.3

1.2

59.20

67.30

—

(3017732) Neutrophils [#/volume] in Blood

896

9602

0.75

14.71

3.0

3.2

5.32

5.02

e9/l

0.32

703

7738

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1133

11757

0.77

14.63

3.0

3.8

18.06

24.42

ug/l

0.44

923

9911

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

8082

62813

1.17

14.18

6.0

8.4

81.00

85.02

u/l

6.73

7496

59064

(3030467) Casts [#/volume] in Urine by Automated count

3830

28173

1.17

13.71

3.7

0.60

0.52

e6/l

0.98

2800

21532

(3009445) Proteinase 3 Ab [Units/volume] in Serum

316

4020

0.64

13.66

1.5

54.32

20.26

iu/ml

—

(40768797) Stomach Pathology biopsy report

1124

11579

0.78

13.63

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7327

63879

0.86

13.57

3.7

4.6

1.18

1.23

mmol/l

7.61

6295

55702

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

148

2288

0.53

13.56

1.8

2.9

113.42

899.78

u/ml

4.79

126

2075

(3020779) Urea [Moles/volume] in Serum or Plasma

993

10375

0.77

13.46

3.9

5.8

11.10

12.37

mmol/l

6.41

915

9726

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4334

39211

0.86

13.27

2.6

3.0

—

estimate

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

9338

73558

1.18

13.23

10.7

13.7

22.03

22.97

u/l

1.69

8840

70432

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1425

14234

0.80

13.23

3.6

5.1

1.01

1.05

mmol/l

5.50

1259

12971

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

337

4187

0.65

13.05

2.6

2.7

—

(3023420) DNA double strand Ab [Units/volume] in Serum

196

2747

0.58

12.72

1.7

1.6

6.62

8.21

iu/ml

0.42

644

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5082

38416

1.15

12.21

4.8

5.0

50.68

104.33

ng/l

3.16

4066

31999

(3005322) IgE [Units/volume] in Serum or Plasma

251

3268

0.62

12.07

1.2

1.3

269.95

243.36

u/ml

0.25

223

2964

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7670

66427

0.87

12.01

4.3

5.4

1.47

1.45

mmol/l

4.88

6742

58832

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

517

5823

0.72

11.74

1.6

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

117

1857

0.51

11.72

1.4

1.3

3.64

4.90

u/ml

0.51

313

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

226

2.56

11.61

1.9

2.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

124

1921

0.53

11.50

1.2

88.00

271.51

titre

3.69

152

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

118

1854

0.52

11.46

1.3

1.2

4.81

5.08

u/ml

0.04

201

(3042631) Mycobacterium sp identified in Specimen

103

1683

0.50

11.31

2.3

2.8

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

751

0.26

11.28

1.4

—

(3009343) pH of Capillary blood

682

7319

0.75

11.23

2.9

3.9

7.42

0.74

570

6138

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

180

2494

0.59

11.22

2.0

2.4

1.67

1.93

mg/l

3.52

145

2148

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1381

13610

0.81

11.13

2.7

3.8

244.55

252.09

u/l

0.83

1244

12762

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

703

7502

0.76

11.11

2.9

3.9

5.17

kpa

0.01

626

7067

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

224

2.51

10.86

1.9

2.0

—

(3000492) Spirometry study

480

5370

0.72

10.46

1.5

1.6

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

103

1637

0.51

10.42

1.3

1.2

2.35

5.42

u/ml

0.90

127

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

200

2639

0.62

10.24

1.4

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

247

3103

0.65

10.15

1.4

1.6

38.01

38.39

u/l

0.11

190

2567

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

278

3408

0.66

10.14

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1202

8160

1.23

10.05

2.2

2.4

56.28

38.88

u/l

0.40

990

6787

(3006270) Folate [Moles/volume] in Blood

180

877

1.70

9.97

1.3

1.2

310.86

308.72

nmol/l

0.05

145

640

(3004809) Band form neutrophils/Leukocytes in Blood

132

1915

0.56

9.84

3.6

3.5

1.97

1.54

0.43

103

1657

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4272

38138

0.88

9.70

3.0

3.6

2169.88

2163.74

ng/l

0.02

3682

33770

(3024891) Influenza virus A+B Ag [Presence] in Specimen

308

1717

1.49

9.67

1.2

—

(3045414) Leukocytes [Presence] in Urine

890

9060

0.79

9.63

2.2

0.00

0.01

estimate

1.64

132

1504

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

136

1940

0.57

9.54

1.3

1.2

32.00

42.05

u/ml

—

(40758558) Short blood count panel - Blood

3256

24174

1.15

9.53

5.5

6.5

—

(3022313) Gas panel - Capillary blood

450

5000

0.73

9.40

3.0

4.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

1399

0.50

9.40

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

188

2460

0.62

9.32

1.3

1.2

0.58

1.01

u/ml

0.71

229

(3015235) Bicarbonate [Moles/volume] in Capillary blood

356

4099

0.71

9.27

2.3

3.1

25.13

24.94

mmol/l

0.41

345

4024

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

141

1976

0.58

9.26

1.5

1.7

14.13

13.20

mg/l

0.57

121

1779

(40768793) Breast Pathology biopsy report

122

1776

0.56

9.23

1.2

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4238

32080

1.13

9.14

5.2

5.1

1.64

1.02

estimate

0.29

779

7957

(3028626) Oxygen [Partial pressure] in Capillary blood

247

3029

0.66

9.06

2.4

3.1

7.45

7.71

kpa

1.58

241

2947

(3007164) IgA [Mass/volume] in Serum or Plasma

1281

12453

0.83

8.84

1.4

1.5

2.77

2.79

g/l

0.07

548

6720

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7819

67116

0.89

8.73

4.3

5.5

4.32

4.27

mmol/l

3.54

6890

59996

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

552

5885

0.76

8.67

1.3

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

245

2.26

8.60

3.0

2.9

27.50

29.04

umol/l

0.60

184

(3045424) Erythrocytes [Presence] in Urine

399

4447

0.73

8.53

2.0

2.1

0.00

0.02

estimate

1.12

102

1053

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1413

0.53

8.42

2.8

3.3

153.08

2422.17

iu/ml

1.08

201

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

224

2758

0.66

8.41

1.5

1.4

6.12

16.72

iu/ml

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

356

2098

1.41

8.39

1.2

—

(3044889) 12 lead EKG panel

6860

53599

1.12

8.31

4.9

5.2

0.56

0.82

0.26

125

(3033658) Prothrombin time (PT) actual/Normal

2949

21920

1.14

8.29

3.6

4.3

80.45

80.51

0.04

2876

21484

(3013139) Helicobacter pylori Ag [Presence] in Stool

457

4969

0.75

8.28

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

359

2124

1.40

8.27

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

359

2127

1.40

8.21

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

146

712

1.70

8.15

1.4

1.3

—

(40768443) Skin Pathology biopsy report

386

4289

0.73

8.10

1.2

—

(40768795) Lymph node Pathology biopsy report

881

0.43

7.98

1.1

1.2

—

(3007566) Smooth muscle Ab [Titer] in Serum

122

1704

0.59

7.97

1.1

120.00

143.84

titre

0.33

125

(3013115) Eosinophils [#/volume] in Blood

4832

42497

0.89

7.97

4.8

5.8

0.20

e9/l

0.53

3934

35984

(3001604) Monocytes [#/volume] in Blood

4686

41282

0.89

7.97

4.7

5.7

0.64

0.65

e9/l

0.82

3827

34392

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

135

1836

0.60

7.94

1.2

1.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

387

2340

1.37

7.85

1.2

—

(3006315) Basophils [#/volume] in Blood

4716

41508

0.89

7.84

4.7

5.7

0.04

e9/l

1.04

3854

34648

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

7.41

7.79

1.0

9316.25

—

ng/l

—

(3021901) Oxygen saturation in Capillary blood

223

2689

0.68

7.57

2.5

3.1

87.58

88.46

1.10

216

2608

(3004616) Nuclear Ab [Presence] in Serum

963

0.47

7.55

1.1

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

154

2003

0.63

7.52

1.2

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

164

2103

0.64

7.52

1.7

1.5

1.14

1.15

g/l

0.07

146

1983

(3042936) Bacteria identified in Isolate by Culture

1443

13693

0.85

7.48

1.9

2.0

—

(3021589) Normoblasts [#/volume] in Blood

3898

34607

0.89

7.46

10.3

13.6

0.00

e9/l

0.70

3032

27927

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

549

5735

0.78

7.39

1.3

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1428

10140

1.18

7.38

2.5

2.6

5.95

6.00

ug/l

0.03

1068

8544

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1458

10371

1.18

7.38

3.3

3.4

236.36

291.47

ng/l

5.02

1352

9573

(3000012) Reticulocyte production index

162

2069

0.64

7.30

1.9

2.1

0.85

0.88

0.35

112

1462

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

161

2058

0.64

7.29

1.7

1.4

0.23

g/l

0.23

143

1936

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

133

1772

0.61

7.23

1.3

1.5

—

(3014271) Vancomycin [Susceptibility]

159

820

1.60

7.20

3.4

3.1

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

163

2072

0.64

7.20

1.2

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1191

8346

1.19

7.18

1.6

—

(3003129) Base excess in Capillary blood by calculation

1171

0.53

7.11

1.8

2.5

1.61

0.50

mmol/l

1.46

1122

(3023419) Bacteria identified in Sputum by Culture

1403

0.57

7.09

2.0

2.4

—

(3035933) Granulocytes/Leukocytes in Blood

127

1702

0.61

7.08

2.7

3.3

61.30

59.74

0.63

127

1702

(4034850) Laboratory test

393

2424

1.34

7.06

12.2

14.8

—

(3000494) Fungus identified in Specimen by Culture

928

9108

0.83

7.05

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

637

6499

0.80

7.03

2.8

3.7

2.04

2.13

mmol/l

0.23

450

4776

(4281824) Cell count and differential, peritoneal fluid

902

0.47

6.99

1.1

1.2

—

(3017354) Segmented neutrophils/Leukocytes in Blood

1225

0.55

6.92

2.8

3.5

58.79

59.03

0.03

1013

(3019198) Lymphocytes [#/volume] in Blood

4808

42087

0.90

6.90

4.8

5.8

1.73

1.83

e9/l

1.91

3968

35964

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

114

1551

0.60

6.79

1.2

1.4

—

(3002030) Lymphocytes/Leukocytes in Blood

4446

39033

0.90

6.68

5.0

6.1

23.86

24.48

3.12

4138

36455

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

256

2.06

6.68

2.5

2.1

61.68

50.07

umol/l

1.77

208

(3022096) Basophils/Leukocytes in Blood

4398

38629

0.90

6.66

5.0

6.1

0.62

0.04

4036

35656

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

140

1806

0.63

6.65

1.2

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

679

0.41

6.63

2.8

3.7

—

(40761536) Microorganisms panel - Urine sediment

693

6956

0.81

6.60

5.1

4.8

—

(1616796) Gas panel - Central venous blood

231

2693

0.70

6.57

3.2

3.9

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

439

4638

0.77

6.50

2.7

3.0

57.09

81.66

mg/l

0.96

381

3915

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

264

2996

0.72

6.41

1.5

1.7

—

(4094501) Cardiovascular stress test using bicycle ergometer

140

1785

0.64

6.32

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

191

2287

0.68

6.32

1.4

1.5

30.11

30.52

g/l

0.21

168

2058

(3008037) Lactate [Moles/volume] in Venous blood

301

3336

0.74

6.29

2.9

3.7

1.81

1.64

mmol/l

1.99

296

3264

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

953

0.52

6.25

1.5

1.8

3.09

3.06

mmol/l

0.08

692

(3019069) Monocytes/Leukocytes in Blood

4418

38704

0.91

6.22

5.0

6.1

9.18

9.26

1.02

4055

35666

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

441

4627

0.78

6.19

2.7

3.0

56.27

54.54

mg/l

0.05

386

3903

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

596

3955

1.25

6.19

1.8

2.1

1035.26

610.17

ug/l

0.61

558

3769

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

827

0.49

6.15

1.2

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

827

0.49

6.15

1.2

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

827

0.49

6.15

1.2

1.4

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1117

0.56

6.11

1.3

0.12

0.25

nmol/l

—

(3044640) Blood type and Crossmatch panel - Blood

3338

29626

0.90

6.03

2.4

2.7

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1099

0.56

5.98

1.3

0.65

2.35

nmol/l

0.53

1046

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

959

0.53

5.95

2.5

4.0

63.40

67.11

u/ml

0.04

934

(3006504) Eosinophils/Leukocytes in Blood

4414

38599

0.91

5.89

4.9

6.0

2.81

2.76

0.65

4051

35593

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

503

0.36

5.89

1.1

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

503

0.36

5.89

1.1

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

503

0.36

5.89

1.1

1.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

406

1.77

5.80

1.0

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

215

2472

0.71

5.70

1.2

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

4633

35921

1.10

5.63

2.9

3.3

129.95

157.36

ug/l

13.58

4157

32227

(3045142) Bone marrow Pathology biopsy report

1100

0.57

5.62

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

282

3100

0.74

5.62

2.9

3.1

—

642.24

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

138

2.33

5.53

3.5

3.0

0.38

0.51

u/field

0.51

138

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1094

0.58

5.52

1.5

1.9

269.20

1400.53

u/ml

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

1047

0.57

5.43

1.8

2.1

61.00

1098.33

u/ml

1.91

1031

(3042111) Morphology [Interpretation] in Bone marrow Narrative

160

1920

0.68

5.42

1.3

1.4

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

501

0.39

5.29

1.1

1.4

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

5404

46667

0.92

5.26

6.2

8.7

4.68

4.51

e9/l

4.03

4500

39726

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1048

0.58

5.26

1.3

1.2

—

17.13

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

982

0.57

5.20

1.3

0.18

0.20

nmol/l

1.01

805

(3052592) Norovirus Ag [Presence] in Stool

224

1.99

5.20

1.4

1.3

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

7310

57972

1.09

5.18

4.0

4.8

15.77

16.41

mm/h

2.33

6574

52990

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

222

2496

0.73

5.17

1.2

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1062

0.59

5.14

1.3

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

894

0.55

5.14

1.2

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1360

9890

1.15

5.13

3.8

5.9

1.50

1.39

mmol/l

2.58

1325

9636

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

192

2204

0.71

5.09

1.9

2.0

3.72

3.68

g/l

0.11

174

2089

(3020876) Protein [Mass/time] in 24 hour Urine

113

1433

0.65

5.07

2.1

2.2

0.96

0.98

g/24h

0.03

796

(3010421) pH of Blood

333

3513

0.77

4.96

3.3

3.9

7.41

0.30

324

3447

(40768441) Liver Pathology biopsy report

486

0.41

4.95

1.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1071

0.60

4.94

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

850

0.55

4.91

1.2

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

279

3009

0.76

4.91

1.8

1.6

—

(40768800) Prostate Pathology biopsy report

180

2074

0.71

4.89

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

103

530

1.60

4.86

1.1

—

4.32

—

(1761482) Bacteria [#/volume] in Urine by Culture

310

3291

0.77

4.85

4.7

5.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

360

0.32

4.84

1.0

1.6

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

360

0.32

4.84

1.0

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

111

1395

0.65

4.80

1.6

1.9

3.01

3.11

ratio

0.47

1128

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

990

0.59

4.80

1.2

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

888

6290

1.17

4.77

2.4

3.5

24.12

24.18

mmol/l

0.21

858

6179

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

126

1541

0.67

4.76

1.3

404.29

395.25

u/l

0.03

114

1460

(3008757) Leukocyte morphology finding [Identifier] in Blood

1127

0.62

4.69

4.4

3.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

521

5182

0.82

4.61

1.3

1.4

—

(3011985) Renin [Units/volume] in Plasma

1050

0.61

4.59

1.2

1.3

39.74

61.20

mu/l

0.89

916

(3018010) Neutrophils/Leukocytes in Blood

4390

38095

0.92

4.57

4.9

6.0

60.49

59.95

2.07

4097

35899

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

163

1886

0.71

4.57

1.3

34.08

39.29

u/l

0.35

138

1605

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1260

0.64

4.56

1.3

1.2

67.37

47.59

u/ml

0.52

142

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

411

4176

0.80

4.48

2.7

2.9

4.36

8.06

ratio

0.62

257

2545

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

174

1977

0.72

4.39

1.9

88.86

88.27

0.14

160

1903

(3004451) EKG impression Narrative

767

0.56

4.37

1.1

1.3

—

(3024928) Oxygen saturation in Venous blood

392

2592

1.25

4.32

1.7

2.4

55.82

57.59

0.76

356

2464

(3000093) Morphology [Interpretation] in Blood Narrative

1103

0.63

4.30

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

792

7535

0.86

4.24

1.8

1.9

173.97

176.96

ug/g

0.06

608

5749

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

334

0.34

4.21

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

226

2452

0.75

4.21

2.5

2.7

16.27

15.61

2.90

220

2401

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

923

0.60

4.18

1.3

—

nmol/l

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1127

10445

0.88

4.18

2.2

2.5

65.38

65.51

g/l

0.23

964

9293

(3032080) INR in Blood by Coagulation assay

6152

48677

1.08

4.18

21.1

22.5

1.44

1.42

inr

1.59

5254

41466

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

819

0.58

4.17

1.1

261.65

295.78

u/ml

0.38

461

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

168

2.01

4.15

1.2

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

123

1466

0.69

4.12

1.3

1.4

6.45

6.38

mmol/l

0.10

110

1387

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

364

0.38

4.07

1.1

1.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

708

0.56

4.06

1.3

13.03

13.84

u/l

0.14

545

(40765096) Chromosome analysis panel by Banding

301

0.33

4.02

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

100

1232

0.67

3.99

1.2

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1836

16494

0.90

3.99

2.0

2.7

0.82

0.81

mmol/l

0.20

1621

15181

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

640

0.54

3.98

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1032

0.64

3.98

1.4

1.6

0.55

0.89

g/l

3.33

790

(4027681) Cerebrospinal fluid IgG ratio and IgG index

177

1.96

3.96

1.1

1.2

0.51

0.52

ratio

0.13

106

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1219

0.67

3.95

1.1

1.3

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

377

3806

0.81

3.91

3.2

4.3

25.04

24.90

mmol/l

0.36

313

3379

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

308

3179

0.79

3.91

1.1

76.04

122.58

u/ml

1.61

1017

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

285

1.74

3.90

1.1

46.86

50.57

mg/l

0.21

242

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

385

3874

0.81

3.87

2.4

2.9

283.35

3343.85

u/ml

2.57

307

3307

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

103

1253

0.67

3.87

1.2

1.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

1182

0.67

3.84

1.5

75.14

64.05

3.12

732

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.75

3.82

1.1

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

102

1239

0.67

3.81

1.6

1.9

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2530

22324

0.92

3.76

2.3

2.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

761

0.59

3.70

1.2

1.4

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

170

1880

0.74

3.67

2.4

2.1

209.16

219.71

0.76

153

1774

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1180

0.67

3.67

1.1

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

447

4406

0.83

3.67

2.1

10.63

10.56

nmol/l

0.05

364

3672

(3020191) Ethanol [Moles/volume] in Serum or Plasma

360

1.63

3.66

1.2

0.77

0.93

promille

0.47

267

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1187

0.68

3.63

1.1

1.3

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

189

2054

0.75

3.62

1.5

28.46

5.34

iu/ml

0.68

500

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

513

0.51

3.61

1.1

43.67

29.19

u/l

0.48

435

(21494434) Karyotype in Bone marrow

967

0.64

3.59

1.1

—

(3037121) Protein [Mass/volume] in Urine

354

3561

0.81

3.58

2.5

2.8

1525.63

665.14

mg/l

0.32

125

1455

(3037692) Legionella sp identified in Specimen by Organism specific culture

307

0.37

3.58

1.0

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1183

0.68

3.57

1.1

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

179

1955

0.75

3.56

1.4

1.5

3798.50

2690.06

e6/l

0.32

119

1388

(40768806) Pleura Pathology biopsy report

151

1691

0.73

3.56

1.4

1.6

—

(3027315) Oxygen [Partial pressure] in Blood

225

2381

0.77

3.54

3.8

4.5

7.86

8.25

kpa

3.82

215

2307

(3018572) Chloride [Moles/volume] in Blood

313

2069

1.25

3.53

4.1

6.1

104.52

104.78

mmol/l

0.37

283

1849

(3039000) Anion gap in Blood by calculation

313

2069

1.25

3.53

4.1

6.1

11.34

11.38

mmol/l

0.07

283

1848

(3011412) CD3 cells [#/volume] in Blood

594

0.55

3.52

2.3

1.7

1080.97

1019.49

e6/l

0.20

543

(3003329) Lymphocytes/Leukocytes in Synovial fluid

902

0.64

3.51

1.5

17.08

26.56

2.49

558

(3027273) Bicarbonate [Moles/volume] in Venous blood

605

5783

0.85

3.49

2.6

3.5

25.28

25.10

mmol/l

0.65

579

5617

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

899

0.64

3.47

1.3

1.2

153.83

162.02

au/ml

0.34

263

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

617

5884

0.86

3.45

2.5

2.6

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

976

0.66

3.42

1.1

1.2

219.48

255.40

pmol/l

1.01

784

(40757373) Influenza virus identified in Isolate

199

1.82

3.41

1.3

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

587

0.56

3.39

1.3

1.5

56.21

68.45

1.25

475

(3028717) Thiamine [Mass/volume] in Blood

2.44

3.39

1.2

61.52

64.06

ug/l

0.24

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

391

0.46

3.38

1.0

298.88

297.09

mg/l

0.04

347

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

369

1.59

3.34

1.2

1.3

—

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

3.80

3.33

1.1

2.00

2.29

—

(3013290) Carbon dioxide [Partial pressure] in Blood

226

2368

0.78

3.31

3.8

4.5

5.00

5.02

kpa

0.13

217

2294

(3012501) Base excess in Blood by calculation

226

2366

0.78

3.29

3.7

4.5

2.81

2.85

mmol/l

0.07

156

1637

(4146454) Self-monitoring of blood glucose

1163

0.69

3.29

2.5

2.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

227

2375

0.78

3.29

2.0

2.3

80.10

101.05

ug/min

0.44

121

1310

(44806420) Estimation of glomerular filtration rate

496

0.53

3.28

2.2

2.7

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

929

8575

0.88

3.27

3.1

4.1

1.23

mmol/l

1.46

749

7311

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

558

0.56

3.25

2.2

23.00

88.00

ug/min

—

139

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

142

1580

0.74

3.24

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

1003

0.67

3.24

1.1

1.2

54.75

61.66

u/l

0.80

876

(3019225) pH of Specimen

1121

10212

0.89

3.16

4.0

4.6

7.35

7.36

0.57

764

7168

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

869

0.65

3.16

1.0

—

(3000330) Specific gravity of Urine by Test strip

605

5735

0.86

3.16

3.8

4.3

1.02

ratio

2.91

523

5189

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

330

1.60

3.14

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

162

1754

0.76

3.09

1.4

1.5

27143.76

63914.03

e6/l

3.37

999

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

453

0.53

3.07

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

670

0.61

3.03

1.2

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

648

0.61

3.00

1.3

1.5

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

2.81

2.97

1.1

1.2

40.88

42.60

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

964

7115

1.12

2.96

4.4

6.1

24.39

24.51

mmol/l

0.46

928

6800

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2694

23500

0.93

2.95

2.6

3.1

36.12

36.90

u/l

0.12

2482

21815

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1591

14184

0.91

2.95

1.2

1.3

1.38

1.64

u/ml

0.60

299

3237

(3004775) Volume in Urine collected for unspecified duration

844

0.66

2.93

2.1

615.14

654.33

0.36

524

(4015189) Microbial culture of sputum

289

0.43

2.90

3.5

2.3

—

(4062490) Immunoglobulin typing, IgG

628

0.61

2.84

1.1

1.4

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

514

0.58

2.83

1.3

1.5

4.00

2.43

0.46

426

(3051611) Lipemic interference index of Serum or Plasma

171

1082

1.30

2.82

3.3

3.5

10.80

11.99

index

1.38

554

(3033099) Centromere Ab [Titer] in Serum

172

0.33

2.81

1.3

1.1

—

(3017569) Oxygen content in Arterial blood

754

0.65

2.77

1.9

2.1

15.79

15.54

0.24

754

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

107

1209

0.73

2.76

1.2

1.3

23.96

13.06

u/l

1.21

1104

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

426

0.54

2.76

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

693

0.64

2.75

3.3

3.1

34.21

31.64

mg/l

0.19

535

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1073

0.71

2.73

1.3

1.4

13.94

13.84

u/l

0.06

1023

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

118

1310

0.74

2.72

1.3

1.4

—

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

3.09

2.70

1.1

1.3

19.29

15.17

—

(40768446) Kidney Pathology biopsy report

191

0.39

2.70

1.0

1.4

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

313

0.47

2.68

1.2

1.1

—

(3035880) pH of Pleural fluid

846

0.68

2.67

1.2

1.3

7.42

7.41

0.11

600

(3024139) IgG subclass 3 [Mass/volume] in Serum

637

0.63

2.66

1.1

1.4

0.44

0.47

g/l

0.26

461

(3028192) IgG subclass 2 [Mass/volume] in Serum

637

0.63

2.66

1.1

1.4

2.80

2.87

g/l

0.11

462

(3027135) IgG subclass 1 [Mass/volume] in Serum

637

0.63

2.66

1.1

1.4

6.63

7.18

g/l

0.45

456

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

786

0.67

2.65

1.1

170.69

636.25

iu/ml

—

122

(3029937) Albumin [Presence] in Urine by Test strip

3290

25780

1.07

2.63

5.2

4.9

0.00

estimate

1.70

815

8641

(3047181) Lactate [Moles/volume] in Blood

432

3044

1.17

2.62

3.8

5.3

1.39

1.36

mmol/l

0.17

386

2708

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

128

1394

0.75

2.60

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

121

1323

0.75

2.54

1.3

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

303

1.55

2.53

1.3

1.4

95.27

78.13

umol/l

0.37

174

(3008898) HLA-B27 [Presence]

1008

0.72

2.51

1.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1917

16833

0.93

2.48

2.2

2.7

19.87

20.42

1.07

1702

15394

(3024354) Oxygen [Partial pressure] in Venous blood

1314

9958

1.10

2.48

2.2

3.1

4.11

4.31

kpa

3.38

1257

9666

(3045788) Cell count panel - Pleural fluid

147

1558

0.77

2.46

1.4

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

350

3388

0.85

2.46

1.2

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

1070

0.73

2.45

1.1

1.2

—

11.18

u/ml

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

190

1.69

2.44

1.3

1.5

0.25

0.30

mmol/l

—

(3026250) Tacrolimus [Mass/volume] in Blood

133

0.31

2.44

26.4

30.9

5.92

6.64

ug/l

—

104

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

150

955

1.30

2.42

1.5

1.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

876

0.70

2.41

1.2

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

1.99

2.40

1.1

1.2

23.25

48.44

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

230

0.43

2.35

2.8

2.1

3.92

837.09

ug/l

0.99

230

(3025130) Human papilloma virus identified in Specimen

383

0.56

2.35

2.0

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

274

2697

0.83

2.34

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

274

0.48

2.32

1.3

1.2

118.75

147.12

mmol/24h

1.08

274

(3023487) Leukocytes [#/volume] in Peritoneal fluid

350

0.54

2.32

1.2

1.8

940.17

5077.88

e6/l

0.85

229

(3012565) Volume of 24 hour Urine

412

0.58

2.30

2.1

2.2

1558.18

1763.74

0.56

346

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

271

1.55

2.29

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

681

0.68

2.26

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

451

0.60

2.26

1.2

1.5

2.50

3.38

—

(21494814) CD8 cells/Lymphocytes in Specimen

271

0.49

2.26

3.1

1.7

25.19

31.59

1.06

271

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

742

6773

0.90

2.24

4.9

7.2

24.21

24.34

mmol/l

0.44

703

6526

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

564

5228

0.88

2.21

1.8

2.97

2.27

ug/l

0.36

424

4515

(3006462) Nitrate [Presence] in Urine

448

0.61

2.21

3.0

4.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

163

0.40

2.19

1.9

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

385

0.58

2.19

1.0

—

(44813793) Dust mix specific IgE antibody measurement

343

0.55

2.19

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

118

1264

0.77

2.19

3.0

3.7

32.57

47.57

u/ml

1.25

111

1223

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

8550

69109

1.06

2.18

5.2

6.2

6.15

6.16

mmol/l

0.19

7542

60779

(4024509) Urine culture

639

4702

1.12

2.15

2.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

371

0.58

2.12

1.7

1.8

215.95

241.40

e6/l

0.39

337

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

451

0.62

2.09

1.0

—

(3047189) Immunofixation for 24 hour Urine

551

0.66

2.08

1.1

1.5

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

2.08

0.0

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

229

0.47

2.07

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

229

0.47

2.07

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

229

0.47

2.07

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

229

0.47

2.07

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

147

0.39

2.05

12.6

13.2

5.74

5.33

mmol/l

—

147

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2045

17790

0.94

2.05

1.6

1.7

1.78

1.66

mg/l

0.75

1617

14230

(3021162) Amylase [Enzymatic activity/volume] in Specimen

135

0.37

2.03

2.5

173.17

1526.43

u/l

—

128

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

163

1.67

2.02

1.1

1.3

87.21

100.15

ug/l

0.25

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

1.92

2.02

2.2

2.4

130.07

129.35

nmol/l

0.01

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

247

1.53

2.01

1.0

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

959

0.74

2.01

1.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

486

0.64

2.00

1.3

705.12

257.75

ug/l

0.32

257

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

124

793

1.29

2.00

1.2

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

537

1.35

1.97

2.6

2.1

1.87

2.63

u/field

0.67

350

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

122

781

1.29

1.96

1.2

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

370

0.60

1.92

1.7

591.90

486.41

e6/l

0.48

314

(3020911) Cortisol [Moles/time] in 24 hour Urine

188

0.44

1.91

1.4

50.80

397.29

nmol/24h

—

188

(21494755) Public health laboratory ask at order entry panel

318

0.57

1.91

1.5

1.4

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8260

69106

0.95

1.91

5.3

6.5

2.42

2.39

mmol/l

2.80

7369

61598

(3019420) Tryptase [Mass/volume] in Serum or Plasma

275

0.54

1.90

1.7

1.4

7.78

12.33

ug/l

0.75

250

(3010838) Calcium [Moles/time] in 24 hour Urine

128

1329

0.79

1.90

1.6

1.7

4.28

4.22

mmol/24h

0.08

1106

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

389

0.61

1.89

1.3

1.1

0.30

0.83

u/ml

2.25

211

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

387

0.62

1.86

1.0

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

166

0.45

1.85

1.0

1.3

158.88

139.74

pmol/l

—

166

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

314

0.58

1.84

1.2

1.7

3871.80

20705.20

e6/l

—

171

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

456

0.65

1.84

2.4

1.8

—

(3016750) Collection duration of Urine

583

0.69

1.83

2.2

1.9

477.22

503.22

min

0.76

400

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2076

17981

0.94

1.82

2.1

2.7

2.17

2.23

g/l

4.50

1841

16341

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

553

0.68

1.82

1.1

—

(3036603) Volume of Urine

628

0.71

1.78

1.7

1.4

1502.80

1745.28

2.23

599

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

113

0.36

1.77

1.2

1.0

—

(4211845) Urine protein measurement

481

0.67

1.76

3.1

4.2

—

(3000034) Microalbumin [Mass/volume] in Urine

826

0.75

1.76

2.7

3.1

32.87

33.65

mg/l

0.02

627

(3028433) Virus identified in Specimen by Culture

257

0.54

1.75

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

1.72

0.0

1.4

—

(3048879) Bone marrow aspiration report

357

0.62

1.69

1.1

1.4

—

2.00

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1433

11083

1.07

1.69

9.8

9.4

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

591

0.71

1.67

1.0

1.1

120.52

113.91

1.07

508

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

484

0.68

1.66

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

473

0.68

1.64

1.1

—

(3020961) Endomysium IgA Ab [Titer] in Serum

263

2505

0.86

1.62

1.1

453.00

227.88

titre

—

(4268621) Lupus anticoagulant assay

471

0.68

1.61

2.2

—

(3000850) Epithelial cells [#/volume] in Urine

2920

23107

1.05

1.61

2.9

5.68

5.13

e6/l

1.49

2645

21002

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

285

2694

0.87

1.59

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

370

0.64

1.57

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

360

0.64

1.57

2.0

2.4

40.00

36.11

0.39

216

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

763

0.75

1.57

1.0

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

329

0.62

1.56

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

554

0.71

1.56

1.5

6.06

6.85

u/l

0.12

434

(3021788) Differential panel - Synovial fluid

190

1850

0.84

1.55

1.5

—

1.00

—

(3029075) Extractable nuclear Ab panel - Serum

358

0.64

1.54

1.1

—

(40758358) Immune stain study

0.00

1.54

0.0

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

926

0.78

1.52

1.4

1.5

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.00

1.51

0.0

14.4

—

205.38

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

123

1244

0.81

1.51

3.1

3.6

—

(3044927) Protein electrophoresis panel - Urine

132

1325

0.82

1.51

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

491

0.70

1.48

5.0

5.2

134.52

130.84

u/ml

—

151

(3023183) Ammonium ion [Moles/volume] in Plasma

266

1903

1.15

1.47

1.5

1.9

23.63

31.86

umol/l

13.63

212

1616

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

508

1.30

1.45

1.2

2.09

2.32

mmol/l

1.46

455

(3016038) Potassium [Moles/volume] in Urine

122

816

1.23

1.44

1.1

34.59

35.21

mmol/l

0.11

688

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

458

0.70

1.42

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

713

0.76

1.42

1.2

1.33

5.01

u/ml

2.83

247

(3029634) Reagin Ab [Titer] in Serum by VDRL

517

1.29

1.42

1.2

1.4

—

2.14

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

260

0.60

1.42

1.4

1.5

14.00

9.11

—

129

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

114

0.43

1.41

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

457

0.70

1.41

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

369

0.67

1.40

6.3

6.2

15.67

164.29

ug/l

1.05

231

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

483

4380

0.90

1.39

2.1

2.5

0.37

0.35

iu/ml

0.44

258

2442

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

407

0.69

1.38

1.3

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

8087

67471

0.96

1.36

22.2

23.2

67.06

66.31

ml/min/173m2

3.17

7590

63616

(3008401) Mugwort IgE Ab [Units/volume] in Serum

307

0.64

1.36

1.0

0.14

1.13

u/ml

—

130

(3044007) Cell count panel - Peritoneal fluid

297

0.64

1.36

1.3

1.7

—

(4195642) Thrombophilia screening test

586

0.74

1.35

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

453

0.71

1.35

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2029

17430

0.95

1.35

3.3

3.7

0.87

0.89

ug/l

0.18

1514

13084

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

133

1315

0.83

1.33

1.2

1.3

0.81

0.83

nmol/l

0.11

112

1068

(3016650) Hepatitis A virus Ab [Presence] in Serum

899

0.79

1.33

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

124

0.46

1.32

1.0

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

200

1414

1.17

1.32

8.1

12.9

8.03

7.31

mmol/l

1.46

159

1160

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

700

6218

0.92

1.30

3.0

4.4

44.93

45.07

0.05

689

6133

(3023520) Reticulocytes [#/volume] in Blood

1348

11701

0.94

1.30

2.1

2.4

64.27

66.90

e9/l

2.12

932

8735

(3038071) Oxygen [Partial pressure] in Mixed venous blood

143

0.52

1.30

4.0

8.0

6.46

5.70

kpa

—

143

(3011335) Digoxin [Mass/volume] in Serum or Plasma

146

0.51

1.29

2.7

2.5

0.79

0.67

ug/l

—

146

(3010144) Erythrocytes [#/volume] in Synovial fluid

958

0.81

1.28

1.2

1.4

190925.00

201147.33

e6/l

0.04

641

(3051387) C reactive protein [Mass/volume] in Capillary blood

287

2089

1.13

1.28

4.1

4.0

32.25

30.45

mg/l

0.33

222

1549

(3036670) Protein [Mass/volume] in Synovial fluid

361

0.68

1.28

1.1

1.2

40.66

39.87

g/l

0.17

168

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

457

0.72

1.27

1.3

1.7

38.35

39.10

g/l

0.36

457

(3014133) Dog dander IgE Ab [Units/volume] in Serum

180

0.55

1.27

1.0

0.02

0.85

u/ml

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

180

0.55

1.27

1.1

1120.08

1679.07

miu/ml

1.48

180

(3003888) Timothy IgE Ab [Units/volume] in Serum

311

0.66

1.26

1.0

1.40

1.65

u/ml

—

134

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

179

0.55

1.25

1.2

1.4

1.54

1.52

g/l

0.05

179

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

680

0.77

1.25

1.1

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1363

10644

1.06

1.24

4.4

6.8

119.22

118.13

g/l

1.26

1333

10390

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

383

1.31

1.24

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1262

9842

1.06

1.21

2.2

2.5

9.18

10.46

umol/l

1.23

1049

8641

(3026389) Candida sp identified in Specimen by Organism specific culture

115

1137

0.83

1.19

1.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

619

0.77

1.19

1.6

1.7

177.69

184.56

pmol/l

0.27

554

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

439

0.73

1.16

1.1

—

(36660697) Celiac disease serology panel - Serum

653

4989

1.08

1.15

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.45

1.14

1.4

1.7

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

214

0.61

1.13

1.4

1.3

1.18

mmol/l

0.05

214

(3051101) Glucose [Moles/volume] in Cord blood

234

0.63

1.13

5.9

5.7

11.19

8.45

mmol/l

3.63

234

(3027035) Albumin [Mass/time] in 24 hour Urine

0.43

1.13

1.2

—

963.11

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

114

0.50

1.11

2.3

1.2

52.60

41.51

mg/l

—

(3018333) Ribosomal P Ab [Presence] in Serum

435

0.74

1.10

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

116

0.50

1.10

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

1.71

1.10

1.3

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

472

0.75

1.10

2.0

1.9

94.47

102.85

umol/l

0.84

472

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

146

1401

0.86

1.09

4.8

5.7

12.92

12.93

mg/l

0.01

124

1268

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.78

1.08

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.78

1.08

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.78

1.08

1.0

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

497

3769

1.09

1.07

2.6

3.6

1.41

1.43

mmol/l

0.10

488

3687

(4212803) Bone marrow aspirate examination

105

1.57

1.06

1.2

1.0

—

(3018133) Calcium [Moles/volume] in Urine

101

0.49

1.06

1.2

1.5

1.10

2.62

mmol/l

—

(3027945) Reticulocytes/Erythrocytes in Blood

1881

14888

1.05

2.1

2.3

1.72

1.78

1.87

1561

12999

(3002619) Bacteria identified in Specimen by Culture

249

0.66

1.05

1.3

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

495

0.76

1.03

3.9

3.0

1.45

1.18

0.34

495

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

232

2146

0.89

1.03

1.6

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

762

6675

0.94

1.03

4.3

6.4

24.96

24.81

mmol/l

0.42

754

6602

(46235355) HIV 1 and 2 tests - Meaningful Use set

693

6090

0.93

1.03

1.3

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

198

0.62

1.03

1.2

3.04

3.73

u/l

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

286

0.69

1.02

2.5

2.1

0.64

0.62

mmol/l

0.49

286

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

265

2429

0.90

1.01

1.7

1.6

47.24

34.86

u/ml

0.58

336

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

593

0.79

0.99

1.1

1.2

86.75

100.42

u/l

0.43

501

(3020650) Glucose [Presence] in Urine

226

0.65

0.99

2.5

1.7

0.00

0.03

estimate

0.80

226

(3051339) Copper [Moles/volume] in Blood

0.00

0.99

0.0

1.2

—

18.31

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.99

0.0

1.0

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3796

30505

1.03

0.98

5.4

6.6

7.13

4.94

ug/l

0.64

3308

26793

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

472

0.77

0.98

1.0

1.1

94.33

90.18

0.66

430

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1049

9082

0.95

0.98

1.6

2.0

0.20

0.19

g/l

2.31

912

8313

(3052851) Hemolysis interference index of Serum or Plasma

397

2997

1.09

0.97

3.4

3.7

2.42

1.81

index

1.34

196

1544

(3022689) Creatine [Moles/volume] in Urine

234

0.67

0.96

1.2

1.4

7.94

6.46

mmol/l

0.54

234

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.87

0.96

1.3

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5151

41614

1.03

0.96

2.9

3.3

49.67

59.12

u/l

9.49

4595

37420

(3023383) Lactate [Moles/volume] in Pleural fluid

470

0.77

0.95

1.3

4.06

3.25

mmol/l

0.83

430

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

606

0.80

0.94

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

606

0.80

0.94

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

614

0.80

0.92

1.0

1.1

—

(44790047) Parainfluenza type 1 nucleic acid detection

109

1052

0.85

0.92

1.2

1.3

—

(44790048) Parainfluenza type 2 nucleic acid detection

109

1052

0.85

0.92

1.2

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

109

1052

0.85

0.92

1.2

1.3

—

(44806118) Parainfluenza type 4 nucleic acid detection

109

1051

0.85

0.91

1.2

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

272

2469

0.90

1.5

1.6

25465.52

14786.73

e6/l

1.38

181

1721

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.47

0.89

1.0

1.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

429

3264

1.08

0.89

1.9

2.4

0.00

g/l

-0.00

377

3008

(3008295) Osmolality of Serum or Plasma

154

1109

1.14

0.89

1.4

1.3

277.73

273.57

mosm/kgh2o

1.02

103

790

(3034092) Cytoplasmic Ig cells/cells in Blood

1.62

0.87

14.4

14.0

0.20

0.27

0.93

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

681

0.82

0.87

1.1

1.2

4.58

5.09

u/ml

0.13

308

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

114

0.58

0.84

4.4

7.1

10.65

10.18

—

114

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

147

0.62

0.82

1.4

1.6

8.02

9.94

ug/l

1.43

147

(3002331) Protein [Mass/volume] in Peritoneal fluid

235

0.70

0.82

1.1

1.3

29.52

52.47

g/l

0.49

195

(3026782) Osmolality of Urine

2563

20524

1.03

0.82

3.0

3.3

548.17

522.67

mosm/kgh2o

8.89

2206

17970

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

263

0.72

0.81

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

575

0.81

0.80

1.1

1.2

31.33

31.72

u/l

0.02

476

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.80

0.0

1.0

—

20.40

—

(3033086) Enterovirus Ab [Titer] in Serum

0.00

0.80

0.0

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

554

4851

0.94

0.79

3.6

4.7

0.91

0.85

2.54

524

4606

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

0.00

0.79

0.0

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.51

0.79

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

125

897

1.15

0.78

1.3

1.4

350.00

429.20

titre

0.20

(3010370) Gastrin [Moles/volume] in Serum or Plasma

104

0.55

0.78

2.0

1.5

39.14

49.36

pmol/l

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

0.78

0.0

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

404

1.22

0.78

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

1.56

0.76

1.2

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.72

0.76

1.0

—

(40762814) Titanium [Mass/volume] in Blood

202

0.69

0.76

2.4

2.1

2.79

3.22

ug/l

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

201

0.70

0.74

1.2

34.11

218.45

u/l

—

134

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.65

0.74

1.1

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

604

5257

0.94

0.73

3.5

4.5

1.57

1.51

1.25

575

5005

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

181

0.68

0.73

1.0

—

1.58

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

657

0.84

0.72

1.1

1.2

101.07

99.19

pmol/l

0.11

657

(3022948) Iron [Moles/volume] in Serum or Plasma

2256

19061

0.97

0.72

2.2

2.7

10.77

11.27

umol/l

2.94

2008

17432

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

247

0.73

0.72

1.3

30.39

29.46

umol/l

0.22

233

(3041918) Cholesterol [Moles/volume] in Pleural fluid

275

0.75

0.72

1.2

1.52

1.39

mmol/l

0.26

170

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

596

5185

0.94

0.71

1.9

2.3

3.84

3.70

g/l

1.11

502

4586

(44816559) Phosphatidylethanol [Mass/volume] in Blood

216

1616

1.10

0.70

1.3

0.31

0.26

mg/l

0.62

556

(3043410) Blood group antigens tested for on Red Blood Cells

311

0.77

0.70

1.8

2.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

846

7281

0.95

0.69

2.4

3.2

126.79

124.98

g/l

1.78

825

7062

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

554

0.83

0.68

1.2

210.91

139.41

titre

0.27

102

(3014891) Appearance of Pleural fluid

255

1.26

0.67

1.4

1.5

—

(4198724) Urine methamphetamine measurement

1.65

0.67

1.3

1.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

599

5196

0.95

0.66

1.9

2.3

4.06

4.17

g/l

2.78

503

4599

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

196

0.71

0.66

1.4

0.11

0.12

nmol/l

0.34

132

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

120

872

1.13

0.66

1.3

1.4

51.25

62.78

titre

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

256

1.25

0.66

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

600

5198

0.95

0.64

1.9

2.3

7.60

7.54

g/l

0.41

504

4595

(1617658) Protocol used for examination of sentinel lymph nodes

540

0.84

0.63

1.1

—

(36303858) Crystals [Presence] in Urine

0.00

0.61

0.0

1.2

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.61

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.61

0.0

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.61

0.0

1.0

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.61

0.0

1.4

—

32.00

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

0.00

0.61

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.61

0.0

6.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

0.00

0.61

0.0

1.2

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

0.00

0.61

0.0

1.0

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

827

7089

0.96

0.59

1.7

2.1

415.73

395.54

nmol/l

1.85

708

6432

(3003396) Base excess in Arterial blood by calculation

1656

13249

1.03

0.59

4.1

6.1

1.08

1.04

mmol/l

0.13

1295

10738

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.59

0.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.59

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.59

0.0

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.59

0.0

1.1

—

0.04

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

110

1018

0.89

0.59

2.3

3.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

153

0.70

0.58

1.1

1.2

15.67

18.04

u/l

—

103

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

535

0.85

0.58

1.0

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

535

0.85

0.58

1.0

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

365

0.81

0.58

1.3

1.4

5.33

6.27

u/l

0.90

294

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

728

0.87

0.57

1.2

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

328

0.80

0.57

1.3

1.4

13.30

22.18

1.28

268

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

171

0.72

0.57

1.4

1.5

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.65

0.56

1.2

1.1

209.83

274.33

nmol/l

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1663

13322

1.03

0.56

4.2

6.1

4.93

5.06

kpa

6.23

1587

12692

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3017

24369

1.02

0.56

4.8

5.4

22.36

22.75

0.71

1563

13997

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

144

1073

1.11

0.55

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

104

0.63

0.55

1.0

1.1

—

1.10

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1661

13315

1.03

0.54

4.2

6.1

11.76

11.63

kpa

0.45

1586

12676

(44786800) Granulocytes/Leukocytes in Body fluid

197

0.75

0.53

1.3

1.4

30.02

21.63

—

154

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

450

0.84

0.53

1.0

1.1

0.23

12.80

nmol/l

—

105

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

809

0.88

0.52

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

477

3733

1.05

0.51

3.8

3.4

0.76

0.82

nmol/l

3.48

386

3018

(3034426) Prothrombin time (PT)

139

0.71

0.51

1.1

1.2

28.08

27.93

0.04

139

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

731

6254

0.96

0.51

1.5

1.7

1.60

1.56

g/l

0.49

595

5340

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1079

8604

1.03

0.50

2.8

3.6

88.55

99.89

ng/l

4.85

898

7081

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

462

3618

1.05

0.49

1.9

2.3

0.02

0.05

g/l

1.07

397

3199

(3036489) Thrombin time

320

2794

0.94

0.49

1.7

20.71

21.76

1.89

294

2573

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1484

11897

1.03

0.49

2.5

3.6

5.83

5.82

kpa

0.03

1425

11583

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

848

7227

0.96

0.49

4.8

7.4

1.40

1.29

3.29

843

7167

(3003181) Sodium [Moles/volume] in Urine

307

2377

1.06

0.49

1.3

1.4

61.83

60.10

mmol/l

0.35

248

1921

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.50

0.49

1.7

1.3

1.60

1.03

u/field

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

139

1043

1.10

0.48

2.5

2.3

2.22

1.69

u/field

0.87

545

(3049717) Cytology report of Urine Cyto stain

566

4863

0.96

0.48

2.8

2.9

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

508

3995

1.05

0.47

2.5

3.2

4.30

4.26

pmol/l

0.44

431

3433

(3038177) Helicobacter pylori Ab [Presence] in Serum

767

0.89

0.47

1.5

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

247

0.80

0.47

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

505

0.86

0.47

1.7

2.1

19.57

24.94

umol/l

0.41

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1.34

0.46

12.5

10.4

14.06

13.97

0.11

(3032057) Clostridioides difficile [Presence] in Stool

269

1.19

0.46

1.6

1.8

—

(3019977) pH of Arterial blood

1654

13298

1.03

0.46

4.2

6.1

7.42

2.01

971

7448

(3046861) Legionella sp Ag [Presence] in Urine

0.59

0.46

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

600

0.88

0.46

1.8

2.4

6.80

7.38

mmol/l

1.31

402

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

145

0.74

0.45

1.0

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

145

1096

1.09

0.45

2.0

1.6

31.47

26.70

u/ml

0.59

216

(3002032) Base excess in Venous blood by calculation

1444

11598

1.03

0.44

2.5

3.6

1.90

1.84

mmol/l

0.23

1238

10000

(3028679) Herpes simplex virus Ab [Presence] in Serum

226

0.80

0.43

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

125

0.72

0.43

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

544

0.88

0.43

1.1

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.63

0.42

1.0

—

(4133840) Spirometry

115

0.72

0.42

1.8

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.41

0.0

4.8

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.41

0.0

1.0

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

1.1

—

0.20

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.81

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.41

0.0

1.1

—

8.28

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

358

0.85

0.41

1.1

—

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

179

0.78

0.41

1.2

1.4

83.11

73.57

—

151

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

188

0.79

0.41

1.2

247.91

284.38

pmol/l

0.24

130

(40761539) Cells [Type] in Urine sediment by Light microscopy

251

0.82

0.41

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

0.00

0.40

0.0

6.5

—

25.34

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.40

0.0

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.68

0.40

1.7

1.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

8287

67803

1.02

0.38

6.8

7.9

41.13

41.03

mmol/mol

0.39

7429

61174

(3020393) Adenovirus Ag [Presence] in Stool

1.34

0.38

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

317

2739

0.95

0.38

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

328

0.85

0.37

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

607

0.89

0.37

1.1

—

3.43

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

442

3491

1.04

0.37

1.9

2.3

0.00

g/l

0.20

378

3018

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

170

1496

0.93

0.37

2.1

2.2

32.96

27.21

mg/l

0.59

496

(3042010) Triglyceride [Moles/volume] in Pleural fluid

212

0.81

0.37

1.1

1.2

0.92

1.73

mmol/l

0.66

130

(3005011) Chlamydia sp Ab [Titer] in Serum

1.37

0.37

2.2

1.8

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

121

0.75

0.36

1.0

1.3

2.61

1.82

umol/l

0.91

105

(3022493) Free Hemoglobin [Mass/volume] in Plasma

441

0.88

0.36

1.0

2.3

55.21

64.86

mg/l

0.79

282

(3022621) pH of Urine by Test strip

878

7028

1.03

0.36

3.6

3.4

6.15

6.06

2.87

697

5100

(3041096) Erythrocytes [Presence] in Urine by Automated

2609

21779

0.98

0.36

4.4

4.5

1.65

0.46

estimate

1.00

708

7547

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

475

0.88

0.36

2.0

2.2

—

(3050794) Legionella sp Ab [Presence] in Serum

0.63

0.36

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

225

1958

0.94

0.35

1.4

1.6

—

(37021550) Renin [Units/volume] in Plasma --upright

166

0.79

0.35

1.3

40.55

78.47

mu/l

1.03

113

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

103

1.28

0.35

4.3

5.4

—

(3001729) Color of Synovial fluid

101

0.73

0.35

1.9

1.6

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1.41

0.35

1.5

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

417

1.13

0.35

1.1

1.3

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

120

0.75

0.35

1.4

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

378

0.87

0.35

1.1

1.2

—

(3025941) Bacteria identified in Stool by Culture

441

3771

0.96

0.35

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.29

0.34

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

324

0.86

0.33

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

375

0.88

0.32

1.1

1.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1954

15825

1.02

0.32

1.7

1.9

29.53

30.13

4.21

1888

15372

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

434

3702

0.96

0.31

1.2

1.3

53.52

58.98

au/ml

0.18

242

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

708

5989

0.97

0.31

5.3

8.1

15.68

15.63

0.22

677

5776

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

534

4535

0.97

0.31

2.0

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

359

1.12

0.31

2.1

2.6

4.91

5.00

kpa

0.27

359

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

359

1.12

0.31

2.1

2.6

9.50

9.99

kpa

0.76

359

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

515

4103

1.03

0.30

2.2

2.5

30.24

22.87

au/ml

0.49

235

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.28

0.30

1.1

109.71

103.11

titre

—

(1002224) Polysomnography panel

136

1049

1.07

0.30

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

206

0.84

0.29

1.1

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5691

47149

0.99

0.29

4.1

6.2

12.68

12.77

umol/l

0.17

5285

44793

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

236

1.15

0.29

1.4

17.47

16.80

pmol/l

0.30

181

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

656

0.92

0.29

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

144

1.20

0.29

1.1

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

0.75

0.29

1.9

1.7

1.64

0.89

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

179

0.83

0.29

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

681

0.92

0.29

1.7

103.43

112.10

ng/l

0.38

681

(3013166) Neutrophils/Leukocytes in Synovial fluid

292

0.87

0.28

1.4

69.27

62.18

0.62

254

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

222

1.15

0.27

1.2

1.3

21.57

31.58

1.24

143

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.76

0.27

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

115

0.79

0.27

1.4

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

131

1015

1.06

0.26

1.6

1.5

6.14

4.68

mg/l

0.38

104

804

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

566

4782

0.97

0.25

2.0

2.3

3.00

2.98

g/l

0.24

470

4180

(3000285) Sodium [Moles/volume] in Blood

240

1.13

0.24

1.4

1.3

137.92

138.06

mmol/l

0.07

202

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

832

6989

0.98

0.24

4.8

7.6

0.69

0.63

3.77

826

6933

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

0.73

0.24

1.0

1.3

—

(3024263) Appearance of Synovial fluid

478

1.08

0.23

1.3

1.5

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

209

0.87

0.23

1.3

1.1

1.07

1.21

u/l

—

106

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.77

0.22

1.6

1.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.21

0.22

1.1

—

(3037756) Immunofixation for Serum or Plasma

327

2777

0.97

0.22

1.4

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1243

10384

0.98

0.22

4.3

4.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.9

—

2.14

—

(3000764) Benzodiazepines [Presence] in Urine

103

1.20

0.21

1.2

1.1

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.4

—

1.68

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

33.78

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

1.52

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.18

0.21

1.2

2682.00

336.07

u/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

680

1.07

0.21

1.5

1.9

8.29

8.15

mmol/l

0.12

680

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

259

1.11

0.21

1.1

51.80

572.42

ng/l

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

0.00

0.21

0.0

8.9

—

55.60

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.21

0.0

1.1

—

0.91

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

233

0.88

0.21

1.4

1.6

0.48

0.38

ug/l

0.42

129

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

163

0.86

0.20

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.20

0.0

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.0

—

2.59

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.20

0.0

1.1

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.20

0.0

1.1

—

160.55

—

(3012544) pH of Venous blood

1479

12016

1.01

0.20

2.6

3.6

7.38

0.32

795

7270

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

223

0.89

0.19

1.2

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

308

1.10

0.19

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

283

0.90

0.19

1.0

1.1

6.43

12.34

iu/ml

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.15

0.19

1.2

1.1

6.25

6.17

mmol/l

—

(44806071) Cardiolipin IgM antibody measurement

1.15

0.17

1.3

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.23

0.17

1.1

1.65

1.68

umol/24h

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.76

0.17

1.2

1.1

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.76

0.17

1.2

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.73

0.17

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.72

0.17

1.0

5.2

—

(3027008) Opiates [Presence] in Urine

106

1.16

0.16

1.2

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

177

0.88

0.16

1.2

1.1

0.56

0.65

umol/24h

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

347

0.92

0.15

5.4

6.2

65.62

72.41

0.63

262

(3028300) Cannabinoids [Presence] in Urine

107

1.15

0.15

1.2

1.1

—

(3020891) Body temperature

629

5259

0.98

0.15

3.1

4.2

36.93

36.90

°c

1.27

620

5194

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

503

4214

0.98

0.15

1.9

—

(3017704) Immunofixation for Urine

675

0.95

0.15

1.6

1.4

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

0.79

0.14

6.6

4.9

47.57

57.56

ug/min

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.79

0.14

1.0

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

115

0.86

0.14

1.0

1.5

8.75

17.99

mm/h

2.97

115

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

218

0.91

0.14

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

132

0.87

0.14

1.1

1.2

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

147

1.12

0.14

1.1

1.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

530

0.95

0.13

1.5

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

411

1.06

0.13

1.1

1.3

1.53

1.16

nmol/l

0.85

290

(3016502) Oxygen saturation in Arterial blood

1451

11832

1.01

0.13

4.3

6.3

95.00

94.98

0.03

1394

11366

(3001019) Free T4 and TSH panel - Serum or Plasma

532

1.05

0.13

1.7

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

182

0.90

0.12

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

543

4401

1.02

0.12

1.9

2.4

1.28

1.12

g/l

0.33

443

3639

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

292

0.93

0.12

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

292

0.93

0.12

1.1

1.2

4.48

13.68

pmol/l

—

107

(3021387) Prolactin [Units/volume] in Serum or Plasma

574

1.05

0.12

2.4

1.9

398.65

326.53

mu/l

0.59

522

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.15

0.11

1.8

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

155

0.90

0.11

1.1

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3410

28181

0.99

0.11

2.3

2.6

59.95

64.72

u/l

0.85

3123

25851

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

190

1.08

0.10

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.08

0.09

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

191

1.08

0.09

1.1

—

(37208534) Antinuclear antibody arbitrary concentration in serum

175

1.08

0.09

1.1

1.0

—

(3007853) Bacteria identified in Skin by Aerobe culture

1318

10772

1.01

0.09

1.7

1.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

296

0.94

0.08

1.1

1.4

53.20

34.69

iu/l

1.50

251

(3001964) Herpes simplex virus Ag [Presence] in Specimen

195

0.93

0.08

1.1

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

1.05

0.08

1.0

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

1.13

0.08

1.6

1.7

—

(3026470) Cobalt [Mass/volume] in Blood

713

0.97

0.08

2.0

2.1

3.04

4.32

ug/l

1.09

657

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

110

0.90

0.08

1.2

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

118

0.91

0.07

1.0

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

101

0.90

0.07

1.2

1.3

—

3984.37

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

207

1732

0.98

0.07

1.6

1.7

35.88

14.49

iu/l

0.28

567

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1027

8506

0.99

0.07

2.7

2.6

0.59

0.54

e6/l

0.25

991

8242

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

177

1.07

0.07

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

105

1.10

0.07

1.2

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.89

0.07

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

193

0.94

0.07

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

0.88

0.06

1.0

1.1

—

199.80

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

709

0.97

0.06

1.2

1.12

1.50

nmol/l

4.32

635

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

251

1.05

0.06

2.3

1.9

13.50

46.81

u/l

2.53

239

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

550

4560

0.99

0.06

1.9

2.3

10.42

10.31

g/l

0.21

447

3895

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

195

1.05

0.05

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

191

0.95

0.05

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

212

1.05

0.05

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

224

0.95

0.04

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

123

1.07

0.04

1.3

1.8

1.72

1.21

ug/l

0.35

114

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

115

1.07

0.04

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.08

0.04

1.8

1.6

—

(3024869) Neuronal Ab [Presence] in Serum

172

1.05

0.04

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

215

0.96

0.04

1.1

1.3

114.06

142.25

nmol/l

0.46

152

(3025577) Chromium [Mass/volume] in Blood

687

1.02

0.04

2.0

2.1

1.88

2.26

ug/l

0.79

579

(3034274) Bile acid [Moles/volume] in Serum --fasting

314

0.97

0.03

1.4

1.2

6.66

13.55

umol/l

1.88

218

(3006576) Bicarbonate [Moles/volume] in Blood

346

0.97

0.03

3.4

6.2

24.77

mmol/l

0.00

314

(3027944) Amphetamines [Presence] in Urine

101

1.06

0.02

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

146

0.96

0.01

1.2

1.3

74.40

76.94

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

332

2722

1.00

0.01

1.3

1.4

265.01

257.27

ug/g

0.29

185

1705

(3000991) Gas panel - Venous blood

1161

9542

1.00

0.01

4.4

7.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

243

0.98

0.00

2.1

2.5

7.00

7.46

mmol/l

0.67

166

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

161

1.02

0.00

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

127

0.97

0.00

1.5

1.6

43.73

48.37

umol/l

0.29

127

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

160

0.98

0.00

1.0

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

178

1466

1.00

0.00

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

347

2853

1.00

0.00

2.0

2.4

126.48

124.48

g/l

0.83

277

2208

(3000060) B lymphocytes [#/volume] in Blood

104

1.03

0.00

1.8

0.09

2.06

e9/l

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

192

0.99

0.00

1.1

—

(3013762) Body weight Measured

0.00

0.0

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.2

—

275.00

—

(3009992) Blasts/cells in Bone marrow

0.00

0.0

1.4

—

6.40

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.00

0.00

1.3

1.2

7.75

12.30

u/l

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

2.3

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.6

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

26.40

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.0

1.0

—

343.00

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

70.20

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.2

—

3.75

—

(3042517) Benzodiazepines panel - Urine

0.00

0.0

1.6

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

2529.86

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

6.7

—

10.14

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.01

-0.00

1.0

15.00

31.61

iu/ml

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.98

-0.00

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.99

-0.00

1.0

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.7

—

3.04

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.98

-0.00

1.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.93

-0.00

1.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

0.99

-0.00

1.2

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.3

—

293.13

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: AD_LO – Alzheimer’s disease (Late onset)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Alzheimer’s disease (Late onset)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Alzheimer’s disease (Late onset) (AD_LO)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints